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Blood clotting, or thrombosis, is an interesting biological application for computational fluid 
dynamics. Existing numerical thrombosis models have previously been shown to be effective for 
low shear rates and simple geometries. For these models to be used in biomedical applications 
such as the design of rotary blood pumps, however, they must first be experimentally validated 
for high shear rates and complex geometries. In this study, we test the ability of a numerical 
thrombosis model to predict thrombosis related phenomena in a high shear flow by creating a 
geometry similar to that of a rotary blood pump. We have applied an existing numerical 
thrombosis model to an annular gap between rotating concentric cylinders, a geometry that is 
closely related to rotary blood pumps. Additionally, we created a physical model of the same 
geometry and exposed blood to a range of shear rates in both the empirical and numerical model. 
The empirical and numerical results are compared in order to evaluate the ability of the 
numerical model to predict thrombosis in similar geometries, such as high shear blood handling 
pumps. 
Fluent was used to solve the coupled convective-diffusion equations along with user defined 
equations that include production and consumption of 7 species critical to thrombosis. These 
equations, along with equations of fluid motion, were solved iteratively within the Fluent solver. 
All reaction constants were from previously published work. At each of the shear rates and 
exposure times tested, the numerical model calculated platelet deposition, platelet-platelet 
aggregation and the two-dimensional distribution of three primary agonists (ADP, thromboxane 
and thrombin) in addition to the standard fluid variables (velocity, pressure, shear rate, etc.) 
A physical model was designed and constructed to control the shear rate to which blood is 




while maintaining laminar flow. In a series of experiments, fresh, heparinized, bovine blood was 
exposed to a constant shear rate ranging from 1,000 to 10,000 s
-1
 for 120 seconds. Prothrombin 
time (PT) and activated partial thromboplastin time (APTT) of the blood was then measured for 
each stress level. 
While the observed changes in thromboembolitic potential (as measured by PT and APTT) of 
the whole blood test samples qualitatively correspond to platelet activation and agonist 
concentration predicted by the numerical model, further work is needed to quantitatively verify 
the numerical model. Thrombosis models based on coupled convective-diffusion equations show 
promise, but need further refinement and validation before they can be trusted to authoritatively 
predict thromboembolitic potential. 
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Thrombosis, the formation of blood clots, remains one of the most significant challenges in 
the design of blood contacting medical devices such as implantable blood pumps, hemodialysis, 
and blood oxygenators [Gartner, 2000]. An attached clot can grow until it obstructs the natural 
flow and a detached or suspended embolus may travel through the blood stream until it 
eventually obstructs a vessel. The design methodology of blood handling devices has progressed 
remarkably in the past years, largely because of the use of finite element analysis and 
computational fluid dynamics [Burgreen, 1996]. Nonetheless, the prediction of thrombosis in 
devices is unsatisfactory because there is not a validated model that can be used for the 
predictions.    
Thrombosis is principally due to three factors: platelet transport, coagulation cascade, and 
haemodynamics. While considerable research has gone into studying the underlying mechanisms 
of thrombosis [Basmadjian, 1997; Chang, 1988; Fogelson. 1984] these models are generally not 
quantitative enough to decidedly predict the occurrence of thrombosis. While many studies of 
thrombosis focus on one of the three mechanisms in order to gain insight into specific area of the 
larger problem, the design process needs a single comprehensive model that includes effects of 
platelets, surface chemistry and haemodynamics. One of the more promising models was 
developed by Sorensen [1999] and included platelets and 5 agonists, chemical species that are 
part of the biochemical cascade of thrombogenesis. The model accounts for the agonist induced 
activation of platelets, enhanced species diffusion, attachment of platelets to the solid surfaces, 
and convective and diffusive transport of platelets by the flow. Goodman [2005] implemented 
the Sorensen model using Fluent, a commercially available CFD package and determined  
reaction rate constants of platelet deposition and embolization from his own experiments.  
2 
To date, this coagulation model has been applied to relatively simple geometries and flow 
regimes such as an abrupt cylindrical contraction or expansion [Goodman, 2005], or 
physiological conditions of shear rate and material [Sorensen, 1999]. The model was compared 
to empirical data and was shown to be effective for these cases [Goodman, 2005; Sorensen, 
1999].  However, the experimental data have been case dependent and more research is needed 
to determine how robust this numerical model is. Unlike physiological flows, the flow within 
blood prostheses is often characterized by high shear rates, bio-reactive materials, and 
turbulence. While the implementation of the model in Fluent make it feasible to apply the model 
to complex geometries such as mechanical blood pumps, the validity of the model in these 
applications is questionable because of both high shear rates and non-biological materials.  
The objective of this study is to test the validity of applying these numerical models to a 
geometry that more closely resembles rotary blood pumps. Specifically, we use the annular flow 
between rotating cylinders to create a shear flow with controllable shear rate. We have 
implemented the thrombosis model on this geometry and conducted numerical experiments by 
varying the shear rate. Additionally, we have designed and constructed a mechanical apparatus to 
expose whole blood to the same conditions. We compare the numerical and empirical results in 









     The platelet is a non-nucleated blood fragment of irregular shape. It will typically have a 
diameter of 2 to 4 microns. In healthy, whole blood they number 250,000 platelets/mm
3
, but 
make up less than 1% of the total blood volume. The main function of platelets is to maintain 
hemostasis by forming a thrombus or clot. Platelets exist in two states: activated and unactivated. 
When visually inspected, unactivated platelets have a variable disc shape. When a platelet 
activates, it forms pseudopods. The pseudopods stretch out like tentacles and give the platelet an 
irregular star shape as seen in Figure 1. When a platelet activates, it also releases chemicals such 
as thromboxane A2 and adenosine diphosphate which further encourage clot formation. Platelet 
activation can occur due to many factors or a combination of factors including contact with sub-
endothelial cells, high concentrations of agonists or exposure to high shear rates. Platelets appear 
purple when viewed under a microscope when a Romanowsky stain is used as seen in Figure 2. 
[Stiene-Martin, 1998; McKenzie, 1996] 
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Figure 1: Image of titanium surface with attached unactivated platelets (top) and attached 
activated platelets (bottom). Note the change in morphology of the activated platelets. From 




Figure 2: Attached platelets on a polycarbonate surface at 10x magnification. The platelets 
are a purple / pink color from the Romanowsky stain. 
  
2.1.2 Coagulation Cascade 
 
     The coagulation cascade is the enzymatic process that ends with fibrin formation and 
ultimately leads to clot formation. The cascade can be activated by contact with either tissue 
factor (extrinsic) or a negatively charged surface (intrinsic). The extrinsic pathway begins 
with tissue thromboplastin (FVII) and the intrinsic pathway begins with Hageman factor (FXII). 
Both pathways lead to the common pathway. In the common pathway, prothrombin (FII) in the 
6 
presence of calcium is converted to thrombin (FIIa). Thrombin with calcium will convert 








Haemostasis is the control of bleeding when a blood vessel is damaged. When blood flows 
past damaged, exposed sub-endothelial tissue, platelets immediately begin to adhere to the 
exposed collagen. In the presence of ADP, platelets will quickly clump to one another as well as 
   
Figure 4: Illustration of the hemostatic process showing platelet attachment, activation and 
fibrin clot formation. From McKenzie, Textbook of Hematology, pg 490. 
to the damaged tissue. Platelets can also adhere to the damaged tissue with the electrostatic force 
between the positively charged calcium ions and the negatively charged platelets and damaged 
tissue.  The platelets then release proteins that, in the presence of ATP and glucose, pull together 
9 
the fibrin clot. This process is called clot retraction. [Platt, 1979] Error! Reference source not 
found. illustrates the clot formation process.  
 
2.2 Experimental Thrombosis Research 
 
 There are many different areas of thrombosis research. Many of them are clinical or 
diseased state studies, and have little direct impact on the current model. The current research is 
focused on platelet transport, platelet attachment to biomaterial surfaces and platelet activation. 
More specifically, the the study focuses on the role that a shear fluid plays in these areas. The 
following sections outline experiments studying the effects of shear on platelets and platelet 
functions. 
2.2.1 Effect of Shear on Platelet Deposition 
 
 Platelet deposition on a biomaterial surface has been the focus of much research; 
however, the influence of shear rate on platelet deposition is still not fully characterized. A 
comparison between Neumann et al. [1980] static exposure and Leonard et al. [1967] flowing 
exposure of fluorinated ethylene propylene (FEP) shows that flowing blood will deposit more 
platelets in the same amount of time. Grabowski et al. [1972] exposed glass to whole canine 
blood at shear rates of 20, 40, and 80 sec
-1
. Grabowski et al. showed that a material has a 
saturation point where that material has the maximum number of platelets deposited on the 
surface. The authors also demonstrated that increasing shear rate increased the rate that a 
material reached its saturation point. There have been several experiments demonstrating 
increasing platelet deposition with increasing shear rate; [Grabowski, 1972; Strong, 1987; 
Turitto, 1975; Hubbell, 1986; Alevriadou, 1993; Schaub, 1999; Jones, 2000] however, the 
10 
highest shear rate studied was 3000s
-1
. [Alevriadou, 1993] These experiments are summarized in 
Table 1. 
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2.2.2 Effects of Shear on Platelet Activation and Aggregation 
 
 Platelet activation plays a large role in thrombosis. There have been several studies 
investigating how exposure to a shear field influences platelet activation. Anderson et al. 
[Anderson, 1978] used a concentric cylinder viscometer to expose platelet rich plasma (PRP) to a 
controlled shear field. The cylinders were designed to be biologically inert to minimize the 
platelet-surface interaction. The authors then measured platelet aggregation and lysis. At a shear 
of 5000 s
-1
, there was a 60% decrease in platelet count due to platelet aggregation in the bulk 
flow. The threshold for platelet lysis for a 5 minute exposure was 5000 s
-1
 and, for a 30 second 
11 
exposure, it was 20,000 s
-1
. Hellums has a vast body of research in the field of thrombosis and 
provides a review in Hellums, 1993. Equation 12 governing shear induced platelet activation was 
developed from the data provided in this review.  
2.2.3 Effects of Shear on Platelet Diffusivity 
 
Many experiments have been conducted to quantify the enhanced diffusion of platelets in 
whole blood. The earliest experiments used platelet rich and platelet poor blood to create a 
washout curve. Platelets were counted using an automatic platelet counter. The highest shear rate 
tested was 440 s
-1 
. These experiments generated a power-law relationship between shear rate and 
effective diffusivity; however the experiments were not sensitive enough to accurately determine 
the relationship between diffusivity and shear rate [Leonard, 1972; Turitto, 1975; Grabowsk, 
1972i; Strong, 1987]. Currently, there are two popular methods of characterizing the enhanced 
diffusion of platelets: Keller [1971] or Zydney and Colton [1982]. Both methods use a linear 
relationship between shear rate and enhanced diffusivity, however each uses a different method 
of determining the diffusion enhancement coefficient (the constant that is multiplied by shear 
rate). To determine the diffusion enhancement coefficient, Keller derives a relationship to the 
diameter of a red blood cell, while Zydney and Colton determine it empirically. Sorensen [1999] 
used the method proposed by Keller, while Goodman [2005] and Wootton [2001] used the 
method proposed by Zydney and Colton. Equation 13 is the equation for the enhanced platelet 
diffusion coefficient used by Goodman and the current research. 5000 s
-1
 is the highest shear rate 
that the enhanced diffusion of platelets has been experimentally validated for [Keller 1986]. 
 Wootton and Goodman both used the method of describing the enhanced diffusion of 
platelets proposed by Zydney and Colton, but each used a different diffusion enhancement 
coefficient. Wootton only considered the experimental results of Zydney and Colton, while 
12 
Goodman calculated the diffusion enhancement coefficient using experimental results from 4 
separate researchers [Hubbel 1986; Turitto 1972; Aarts 1986; Zydney 1982]. Wooton used a 
diffusion enhancement coefficient of 7E-9, while Goodman calculated it to be 6E-10. The 


































Figure 5: The difference in the enhanced platelet diffusion of Goodman and Wootton. 
Goodman used a diffusion enhancement coefficient of 6E-10 and Wootton used 7E-9.  
2.2.4 Platelet Embolization 
  
Goodman et al. provide the only quantitative measure of platelet embolization due to shear. 
Goodman conducted a series of experiments in which he exposed polyethylene (PE) tubing to 
whole blood at a steady flow rate for 3 min. The authors then rinsed the tubing with a saline 
13 
solution at varying shear rates from 0 to 6000 s
-1
. Goodman et al. then took a measure of percent 





where embF is the percent platelets remaining and γ is the shear rate.  Equation 1 is used to 
calculate Boundary Source Term #1 in Table 3. 
2.3 Analytical and Computational Models of Thrombosis 
2.3.1 Haemodynamic Models 
 
 Haemodynamic models use information from the flow field such as shear rate and 
reattachment points to estimate how and where thrombosis or other particle mediated deposits 
will form [Nazemi, 1989; Kleinstreuer, 1991; Lee, 1995]. Fry reported findings of atherosclerotic 
plaque formation in vascular bifurcations and proposed a critical shear stress at which plaque 
begins to form. [Fry 1969, 1973] Fry defined the critical shear stress to be 0.5 of the shear stress 
for Poiseuille flow in a pipe of the same diameter. Nazemi et al. applied Fry’s method to an 
aortic bifurcation. [Nazemi, 1989] They solved the conservation of mass and momentum 
equations using the Galerkin finite element method. The wall shear stress was then calculated. 
The locations with wall shear stress less than the critical shear stress were identified and a thin 
sinusoidal mass layer was placed onto the wall. The mesh was redefined to incorporate the new 
sinusoidal wall and the governing fluid equations were resolved. This iterative process developed 
a solution for plaque formation and growth on the vascular wall. The size and location of the 
plaque formation coincided with clinical observations of the aortic bifurcation. This model has 
 γ0095.0−= eFemb
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only been applied to bifurcating geometries. While this model was shown to be effective at 
predicting plaque formation in a bifurcation, this model is highly influenced by the previous 
knowledge of plaque formation in this particular geometry. The applicability of this model to 
more complex geometries is questionable mainly do to the difficulty of determining a critical 
shear stress were Poiseuille flow is not applicable (i.e. blood pump).  
 
2.3.2 Cascade Models 
 
 The coagulation cascade has total of 13 inactive factors and another 6 active factors. 
Hockin et al. [2002] developed a strict stoichiometric model that contained all the coagulation 
factors. This model contained 27 chemical expressions to stoichiometrically describe the 
coagulation cascade. This model provided insight into the limiting factors of the cascade. 
However, the rate constants and results only apply when phospholipid concentrations are 
saturated. The work of Basmadjian et al. [1997] provided results that are much more applicable 
to biomedical applications. First, they took into account mass transport, addressing the fact that 
the blood is flowing over a surface. Second, they developed solutions for low, intermediate and 
high flow. Next, the authors investigated the intrinsic and extrinsic paths separately. Finally, a 
time dependent solution was generated for thrombin concentration. This solution was sensitive 
enough to capture the positive feedback loop created by the coagulation factors. This model, 
while powerful, was still relatively simple and could potentially be implemented into CFD in its 
entirety.  
2.3.3 Platelet Adhesion Models 
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 One of the first mathematical models of platelet mediated thrombosis came from a group 
of researchers out of Columbia University [Grabowski, 1972; Leonard, 1972; Turitto, 1975]. 
 This research group used the coupled convection-diffusion equation (Equation 5) to model 
platelet transport in whole blood flowing through a cylinder. They non-dimensionalized the 
equation and developed an asymptotic solution. This research group did extensive work 
developing the enhanced diffusivity of platelets in whole blood, the adhesion rate constant for 
platelets on biomaterials, and began to look at how the biomaterial surface affects platelet 
adhesion. These researchers performed a strict and thorough analytical solution to the governing 
differential equations; however, some limiting assumptions had to be made to render these 
equations analytically solvable and these assumptions limit the efficacy of the solution. The 
largest of these assumptions include a time independent solution and diffusion-limited platelet 
adhesion. It was later shown that a time dependent solution is necessary to capture the positive 
feedback loop of platelet adhesion [Sorensen, 1999], and that platelet adhesion in a non-creeping 
flow cannot be considered diffusion limited [Strong, 1987]. This model also did not include 
any other species or factors of the coagulation cascade. Given the assumptions made and 
the relative simplicity of the model, this model determined the diffusion enhancement coefficient 
with 95% confidence and compared well with experimental results of platelet surface coverage 
on glass.   
      Research from the University of Utah lead by Aaron Fogelson took advantage of new 
technology to develop a finite element scheme to describe the phenomena of thrombosis. In 
Fogelson's early work [Fogelson, 1984], he did rigorous development of the numerical methods 
required to solve the governing equations. This publication was the foundation for numerical 
solutions to not only thrombosis models, but any simulation using the coupled convection-
16 
diffusion equation. Fogelson continued with a similar model to Grabowski et. al. but made many 
improvements. This improved model could differentiate between activated and unactivated 
platelets where activated platelets were more likely to attach to the biomaterial surface and other 
platelets. Fogelson also added the species ADP to his model. ADP was released when a platelet 
was activated and platelets would activate when a threshold concentration of ADP was reached. 
Platelets were also modeled with a radius and not as discrete points, so when platelets deposit on 
the surface or aggregate together, the flow field is re-solved around them. Fogelson also 
developed a complex scheme to describe the connection between aggregated platelets. In this 
scheme, the link between platelets could stretch and flex from the forces of the flow field. While 
this model contained many novel improvements, it also contained some shortcomings. Fogelson 
applies this model to a narrow blood vessel that has a Reynolds number less than 0.1, and he 
therefore neglects inertial effects. Due to this simplifying assumption and low Reynolds number, 
he now only has to solve the Stoke's equation of fluid motion. This flow field also has a low, 
physiological shear rate, so he can neglect the effects of shear (activation, aggregation and 
enhanced diffusion) on platelets. While this makes his solution simpler, it renders his model 
useless for anything besides a creeping flow. Later, Fogelson went on to develop different 
versions of thrombosis models including an in-depth study of the platelet-platelet link [Fogelson, 
1992] and a model purely of the coagulation cascade [Fogelson, 2003]. While Fogelson has 
made tremendous contributions to the field of thrombosis modeling, currently there is no 
experimental validation for any of Fogelson's models.   
     The research group from Rice University developed a model for thrombosis that included 
more of the platelet released agonists [Hubbell, 1986; Folie, 1989]. This model specifically 
looked at the effects of an attached thrombus on the flow field. They used the convection-
17 
diffusion equation to calculate the concentrations of ADP, TxA2, and thrombin in the flow field 
around the attached thrombus. This group also used the commercial computational fluid 
dynamics (CFD) program FIDAP to solve the conservation of mass and momentum equations as 
well as the convection-diffusion equations. [Folie, 1989]  
 Sorensen et al. [1999] developed a fairly comprehensive model of thrombosis. This 
computational simulation was able to generate a time dependent solution that was able to model 
the synergistic effect of platelet attachment and agonist release. This model also included a 
surface availability function to simulate the tendency for platelets to initially adhere as a 
monolayer [Grabowski, 1972]. The Sorensen et al. model compared well to experimental results 
of parallel plate flow for shear rates of 100 and 500 s
-1
 but did not compare well for a shear rate 
of 1500 s
-1
. Goodman et al. [2005] added to this model an embolization term that allows adhered 
platelets to embolize and return to the bulk flow after sufficient exposure to shear. The Goodman 
et al. model is used in the current research and is discussed further in the Methods section.   
 The highest shear rate used in the prior computational models was 5800 s
-1
. This shear 
rate was produced in the small diameter of Goodman’s et al. abrupt expansion and contraction 
geometry. However, in Goodman’s single pass flow cell, exposure to this shear rate was brief 





3.1 Geometry  
 
An annular gap between rotating concentric-cylinders was chosen for its machinability and 
similarity to an axial flow blood pump (shown in Figure 6). The shear rate within the annular gap 
is varied by controlling the rotational speed of the outer cylinder. The maximum shear rate is 
9500 s
-1
, which is typical of an axial flow blood pump and higher than previously tested with this 
numerical model. The radial dimensions, angular velocity, and Reynolds number at this shear 
rate are listed in Table 2. The annular gap is 0.014 in (0.36 mm) in order to maintain laminar 
flow (Re < 1,500) over the range of rotational speeds. The outer cylinder is rotated in order to 
avoid any Taylor instabilities [Tritton, 2003].  
 
Figure 6: Flow geometry 
 
 




Inner radius (mm) 16.3 
Gap (mm) 0.36 
Angular velocity (rad/s) 445 
Reynolds number 459 







3.2 Test Rig Design and Construction 
 
A device (Figure 6) was designed and constructed for the purpose of exposing the blood to a 
known, constant and controlled shear rate. Natural polycarbonate was chosen for the blood 
contacting test section because of its optical clarity and its common usage in blood handling 
devices. Appendix F gives a full parts list and drawing package for this test rig.  
 
Figure 7: Test rig assembly, 1: DC motor; 2: Inner cylinder held static; 3: Outer cylinder 




 3.3 Blood Collection 
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Fresh, whole bovine blood was collected by relieving the hide and puncturing the carotid 
artery. The freely flowing blood was then collected in polyvinyl chloride (PVC) container 
containing enough heparin (porcine intestinal mucosa, EMD Chemicals INC (Biosciences), 
Darmstadt, Germany) to reach a final concentration of 1.5 U/ml. The blood was then transferred 
to a sterile Polyethylene Terephthalate Glycol (PETG) container (VWR International) for 
storage. The process was done at a local slaughterhouse in accordance with all USDA 
regulations. Appendix D gives a full standard operating procedure for the blood collection. 
 
3.4 Exposing Blood to Shear 
 
Because of the instability of blood, great care was taken to replicate the method for each 
individual trial. 2 mL of blood was pipetted from the PETG storage container using a variable 
volume pipettor (VWR International). The blood was then placed in the annular gap test section. 
The test rig was then turned on and the speed adjusted to the desired rpm. The time from when 
the blood is placed in the test section until the desired rpm was reached was 30 seconds for all 
trials. The blood was exposed to the desired shear rate for an additional 120 seconds. The blood 
was pipetted from the test section and placed in a sterile, borosilicate glass test tube.  
Three different shear rates, 2200, 6600, and 9500s
-1
, were tested in this experiment and 
compared to a control of 0 shear (simply exposing the blood to the section). This control was 
chosen in order to isolate the effects of shear stress on the whole blood, while including any 
effect of exposure to the material. 9500s
-1 
was chosen as the maximum shear rate  Two or three 
trials were run at each shear rate. One outlying data point was omitted from the results because 
the BBL Fibro System malfunctioned. 
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3.5 Coagulation Measurement 
 
Each whole blood sample was centrifuged for 10 minutes and approximately 1mL of plasma 
was collected for each trial. The BBL Fibro System (Becton Dickinson Microbiology Systems, 
NJ) was used to measure coagulation by conducting the prothrombin time (PT) and activated 
partial thromboplastin time (APTT) tests. PT and APTT are medical standards for measuring 
coagulation and detailed methods have been well documented [Stiene-Martin, 1998]. PT 
measures the extrinsic pathway, which is activated by exposure to damaged endothelial cells, and 
APTT measures the intrinsic pathway, which is activated by exposure to any negatively charged 
surface. Both the PT and APTT are indirect measures of prothrombin and thrombin which are the 
final and most important factors for fibrin clot formation, and both of these coagulation factors 
are included in my computational model. A shorter PT or APTT indicates that more coagulation 
factors are present and clot formation is occuring more rapidly. The vise versa is also true. PT 
and APTT of the blood were then measured for each stress level. The variance of the test data 
“R” was found by linear regression and solved in Microsoft Excel.  
After the trials at the highest shear rate, the polycarbonate inner cylinder was inspected for 
platelet attachment with microscopy. Directly after each trial, the inner cylinder was rinsed with 
a 0.9% NaCl solution. The surface was then stained with Wright stain in order to visualize the 
platelets. A Keyence VHX-500 (Keyence Corporation of America, NJ) digital microscope was 




4 Computational Methods 
 
 
4.1 Numerical Methods 
 
The governing fluid equations were solved using a commercially available CFD package, 
Fluent 6.3 (Fluent Inc., Lebanon, NH). A control-volume approach was used and the geometry 
was discetized into quadrilateral elements. Blood was modeled as a Newtonian fluid with a 
viscosity of 3 cp [Goodman, 2005]. The conservation of mass or continuity equation can be 






where   
r 
u  is the velocity vector, ρ  is the density of the fluid and Sm is the source term to 
account for any mass added to the system. This is the general form of the equation and is 
applicable to both compressible and incompressible fluids. The general form of the conservation 
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F  are the gravitational and body forces, and the stress 
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where µ is the molecular viscosity and I  is the unit tensor. The coupled convection-diffusion 
equation can be written as Equation 5 
 
 Equation 5 
 
where Ci  is the mass fraction of the ith species, Si  is the souce term for the ith species and Ji  







where Di,E  is the enhanced diffusivity for the ith species. Fluent solves each of these equations 
iteratively with time to generate the flow field and species concentrations for each grid cell.  
 The species transport solver in Fluent uses the convection-diffusion equation (Equation 
5) to model individual species transport in a flowing medium. This equation is valid for species 
with a low (<0.001) mass fraction and particles small enough that they do not disrupt the flow 
field. The entire solution process is illustrated in Figure 8. The simulation is started by 
initializing the problem by inputting values of initial velocity and species concentrations. Fluent 
then performs its first iteration by iterating the momentum, continuity, energy, and species 
transport equations. This generates values of the velocity field, shear rate and species 
concentration for each grid cell. These values are inputted into the UDF. The UDF then 
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for convergence by comparing the residual of each equation to the convergence criteria. If the 
residual is larger than the convergence criteria, Fluent preforms another iteration beginning by 
iterating the equations of fluid motion. If the residual is smaller than the convergence criteria, 
Fluent moves to the next physical time step. A listing of the steps taken to implement this model 
in Fluent are given in Appendix A. 
 
Figure 8: Flow chart of solution process in Fluent. Items in circles are input or output 
values to or from the solver. Items in solid squares are functions performed by the solver. 
The dashed line encompasses the loop of functions that Fluent performs each iteration.  
 
The CFD simulation is not an exact representation of the actual physical geometry, so some 
assumptions must be made. A CFD is 2-D and therefore assumes that there is a negligible 
gradient longitudinally along the cylinder and also neglects the end effects of the bottom of the 
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cylinder. Periodic boundary conditions were used to reduce the computational domain and 
assume a negligible circumfirencial gradient due to the symmetric geometry. The time for the 
cylinder to reach full speed is different between the experiment and the CFD and the effects of 
these beginning seconds is assumed negligible when compared to the 120 second duration of the 
experiment. The flow regime is assumed to be laminar due to the calculated Reynolds number of 
450 for the highest shear rate. And finally, while blood is know to be a non-Newtonian fluid it is 
assumed to have a constant viscocity because these flow regimes are well above the critical shear 
rate 1000 s
-1 
[Hellums, 1993].  





     
The Peclet number is a measure of relative importance of convective terms to diffusive terms 
where U is a characteristic velocity, a is characteristic length and D is normally the Brownian 
diffusivity of a species, but for this research the effective diffusivity will be used. A large Peclet 
number compared to unity indicates a dominant convective term. For this geometry, the Peclet 
number is only dependent on the characteristic length a. For the bulk flow a=3.5e-3 cm and Pe is 
on the order of 10
4
 in the circumferential direction. In the radial direction, velocity is close to 0 
and Pe is small compared to unity. Therefore, convection is the dominant term for platelet 
transport in the bulk flow, but diffusion is dominant for platelet transport in the radial direction.  
Also, the velocity near the inner wall will be close to zero while the shear will remain constant, 







4.2 Thrombosis Model 
4.2.1 Included Species 
 
The species included in the numerical thrombosis model consist of unactivated platelets, 
activated platelets and 5 agonists of thrombogenesis (ADP, TxA2, prothrombin, thrombin and 
antithrombin). The abbreviation and source terms for each species are given in Table 3. These 
species were chosen due to their major role in platelet activation, deposition, and aggregation. 
The use of these species was first proposed by the model developed by Hubbell and McIntire 
(Hubbell, 1986). While von Willebrand factor has been included in previous models, it is not 
included in the current model. The given parameters for each of the species including initial 
concentration and Brownian diffusivity Db are given in Table 5.  
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Table 3: List of included species and their sournce terms 
 
# Species Abbreviation  Bulk Source Term Boundary SourceTerm
1 Unactivated Platelets Pl -kpa [Pl] -S(x,t)kps [Pl]+Femb M(x,t)
2 Activated Platelets AP +kpa [Pl] -S(x,t)kas [AP]-Ma (x,t)/M∞ kt [AP]
3 Adenosine diphosphate ADP +λkpa [Pl] ----
4 Thromboxane A2 TxA2  +st[AP]+kj [TxA2] +Ma (x,t) st
5 Prothrombin pT  -[pT](Φat[AP]+Φrt [Pl])  -[pT](Φpt Mu (x,t) + Φat Ma(x,t))
6 Thrombin T  +[pT](Φat[AP]+Φrt [Pl])-Γ[T]  [pT](Φpt Mu (x,t) + Φat Ma(x,t))
7 Antithrombin III aT -Γ[T] ---
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Table 4: List of symbols in Table 3 
Symbol Description Value
Mu
Concentration of unactivated platelets 
on the surface (plt m^-2)
-
Ma
Concentration of activated platelets on 
the surface (plt m^-2)
-
M∞
Total capacity of the surface for 
platelets (plt m^-2) -
kps
rate constant for unactivated platelets 
adhering to surface (m s^-1) 2.5 x 10
-6
kas
rate constant for activated platelets 
adhering to surface (m s^-1) 3.5 x 10
-3
kt
rate constant for platelets adhering to 
other platelets (m s^-1) 3.5 x 10
-3
Femb
fraction of surface-adherent platelets 
that embolize during each time step Eq. 1
λ
Amount of ADP released from platelet 
granules (nmol / plt) 2.4 x 10
-8
st rate of synthesis of TxA2 (mol [AP]^-1) 9.5 x 10
-12
kj rate of TxA2 inactivation (s^-1) 0.0161
Φat
thrombin generation rate on the 





thrombin generation rate on the 





calculated rate for heparin-catalyzed 
















MW (g/mol) Db(cm^2 s^-1) 












ADP 0 µM 0 424.4 2.57 x 10
-6
TxA2 0 µM 0 352.5 2.14 x 10
-6
pT 1.1 µM 0.000075 72000 3.32 x 10
-7
T 0 µM 0 36600 4.16 x 10
-7
aT 2.84 µM 0.000167 62000 3.49 x 10
-7
 
4.2.2 Platelet Deposition 
 
Platelet deposition and attached platelet agonist release are modeled using a set of boundary 
source terms shown in Table 3 in the Boundary Source Term column. These boundary source 
terms are written by the user as a User Defined Function (UDF) and each is implemented in 
separate convection-diffusion equation (Equation 5). Because these are boundary source terms, 
they are only applied to nodes designated as wall nodes.  
The kinetic constant of platelet adhesion (kps and kas in Table 3  Boundary Source Terms #1 
and #2) is the constant that determines the rate at which platelets adhere to the surface.  
Unfortunately, this constant is not widely used and there is little available empirical data. 
Previous researchers have used scanning electron microscopy (SEM) to measure platelet 
adhesion to polyethylene and fit the numerical data to the experimental data by changing the 
constant [Goodman, 2005]. In addition, previous experiments with polyethylene and silicon 
rubber lead to the conclusion that the difference in platelet adhesion on polymer surfaces is not 
significant [Goodman, 2005] Therefore, this research used the most recently published value for 
the kinetic constant of platelet adhesion of 2.5e-6 m s
-1
 for unactivated platelets and 3.5e-3 m s
-1 
for activated platelets.  
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Platelets have been observed to initially adhere in monolayer on the biomaterial surface 
[Grabowski, 1967] and also are more likely to adhere to a surface that is not already populated 
by adhered platelets. These phenomena are taken into account by the surface availability function 




where ∞M  is the total available surface area and M(x,t) is current surface area occupied by 




 When a platelet attaches to the surface, it releases agonists (txA2, pt, th) that further 
promote platelet deposition and activation. Attached platelet agonist release is included in this 
model as Boundary Source Terms #4, #5, and #6 in Table 3. 
4.2.3 Platelet Activation and Agonist Release 
 
Platelet activation and agonist release are governed by the set of source terms shown in Table 
3. These source terms are written by the user in a UDF. Each source term is implemented as the 
source term in Equation 5. Each species has a separate convection-diffusion equation (Equation 
5) with the appropriate source term.  
There are two modes of platelet activation included in this model: agonist induced activation 
and shear induced activation. Agonist induced activation is dependent upon a weighted 
summation of the concentrations of ADP, TxA2, and thrombin.   When this summation reaches a 















critical threshold, pak  (Bulk Source Terms #1, #2, and #3 in Table 3) changes from 0 to >0 and 










where ja  is the concentration of the jth agonist and critja ,  and jw  are the critical 
concentration for activation and the weight of the jth agonist as shown in Table 6 






ADP 2 µM 1
TxA2 0.6 µM 3.3
T 0.01 U ml^-1 220  
 
The rate of platelet activation is proportional to the concentration of the agonists.  
 Shear induced activation is based on the work of Hellums [Hellums, 1993] and is 

























 3.26104 −= τxt
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t is the time to activation and τ  is the shear the platelet is exposed to (dynes cm-2 ). The time to 
activation and the shear stress are tracked in the UDF.  
Upon activation, platelets release ADP, TxA2, prothrombin, and thrombin (Bulk Source 
Terms #3, #4, #5, #6 in Table 3) which creates a positive feedback loop because these species 
further encourage platelet activation. Figure 9 is a flow chart illustrating the feedback loop as 





Figure 9: Schematic of platelet activation and thrombus formation. Solid lines are 
pathways to the various platelet states and dashed lines represent the feedback loop due to 




4.2.4 Thrombus Growth 
 
The current model allows for grid cells that contains a higher volume of platelets than the 
volume of the grid cell to be converted to a solid. This solid represents a thrombus and does not 
allow fluid to flow through the grid element. In this way, a clot can “grow” by converting 
adjacent numerical elements to thrombus. Additionally, attached thrombus can also embolize and 
attached platelets may return to the bulk flow as unactivated platelets.  
4.2.5 Enhanced Platelet Diffusion 
 
The motion of red blood cells (RBC) in flowing whole blood has been observed to enhance 
the diffusivity of other particles in the blood [Strong, 1987; Wootton, 2001]. The enhanced 
diffusivities for unactivated platelets, activated platelets, prothrombin, thrombin and 
antithrombin III were accounted for. The other species (ADP and TxA2) are too small to be 
affected by the RBC motion; therefore, the Brownian diffusivity was used for these species. The 
diffusion coefficient for each species (enhanced and Brownian) was taken from the literature. 





where De is the effective diffusivity, Db is the Brownian diffusivity, β  is the diffusion-
enhancement coefficient (=6.0e-10 cm^2) and γ  is the maximum local shear rate. The effective 
diffusivity can be several orders of magnitude greater than the Brownian diffusivity for high 





4.3 Validation of Model by Comparing with Previously 
Published Results 
 
The previously published results of flow through an axisymmetric stenosis from Goodman 
[2005] were reproduced to ensure that our numerical model was working and implemented 
correctly. All of the simulation parameters were exactly replicated with the exception of mesh 
size, due to computational expense. We used a mesh size of 2 microns whereas Goodman used 
0.5 micron. The geometry of an abrupt contraction and expansion was modeled with a two-
dimensional, axi-symmetric mesh.  
 
4.4 Numerical Model Applied to Annular Gap 
 
4.4.1 Boundary Conditions 
 
The cylindrical annular gap was solved using a two-dimensional, unsteady, laminar solver in 
Fluent. Rotational periodic boundary conditions were used to simulate a 0.048 radian portion of 
the geometry (Figure 10). A structured mesh was used to represent this characteristic volume. 
The outer wall was set as a rotating boundary condition and the inner wall is a fixed wall. The 
bulk fluid is initially at rest, but develops as it is driven by the outer wall rotating at a constant 
angular velocity. For a shear rate of 10,000 s
-1 
, the outer wall was set to rotate at 4000 rpm. Each 
simulation was run for 120 seconds for a total of 8000 revolutions.  
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Figure 10: Schematic of complete flow geometry compared to computational domain with 
labeled boundary conditions 1: Rotational periodic; 2: Stationary wall; 3: Rotating wall 
4.4.2 Modifications to the previous model 
 
The following modifications of the implementation of Goodman were made in order to 
produce a well posed problem. First, periodic boundary conditions were used. Periodic 
boundaries must come in pairs and the paired boundaries are treated as neighbors, so whatever is 
the output of one boundary is the input to the other. Secondly, as there was no flow rate or 
pressure difference specified for this simulation, the rotating outer boundary is the only cause for 
convection. Because there is no inlet boundary condition, a method of inputting initial species 
concentration was determined. A user defined function was written that added a second source 
term to the diffusion equation. This source term was turned on only for the first time step of the 
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simulation and the appropriate initial species concentration was reached. The source was then 
turned off and only the original source terms remain.  
4.4.3 Model convergence 
 
The rotating boundary problem is a fairly common problem in CFD, especially in the field of 
turbomachinery. To produce a converged solution, the rotation boundary condition was set to an 
RPM of about 0.5 to 0.25 of the final RPM. A converged solution is reached using a small 
numerical time step (1e-5 sec) when compared to the total solution time (120 sec). The RPM is 
then raised incrementally and a converged solution is reached for each RPM until the desired 
RPM is reached. This “ramp up” method produces a better converged solution with less 
computational expense. For this research, the desired RPM was reached in about 1e-3 sec of flow 
time.  
The simulation was run to convergence criteria of 1e-4 for the weighted residuals of 
continuity, velocity and convection-diffusion of each species. The simulation was started with a 
time step of 1e-5 sec for stability, and was later incrementally increased to 0.01 sec. The PISO 
pressure-velocity coupling proved to be more stable than other methods. The under-relaxation 
factors were not changed from the default settings. A grid study comparing shear rate with 
element sizes of 10, 5, and 2 microns and a separate grid study comparing platelet depsotion with 
element sizes of 10 and 5 microns were conducted. 120 sec of flow time solution required about 
48 computer hours on a single 2.8 GHz AMD Opteron processor with 32GB of RAM for a grid 
size of 5 microns (5600 grid elements). A solution for a 2 micron grid was attempted. The rate of 
solution for one week was interpolated out to determine that 120 sec of flow time would require 






Figure 11 shows the results from the PT and APTT tests described in chapter 3.5 as a 
function of shear rate. Although regression showed the data to be statistically insignificant, a 
trend of decreasing time is seen from the linear fit lines. The decreasing PT and APTT indicate 
that coagulation is occuring more rapidly and higher levels of coagulation factors such as 
thrombin and prothrombin are in the blood. The control PT and APTT (0 shear) of these 

































Figure 11: Measured PT and APTT 
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respectively. The normal PT and APTT are about 12 and 25 respectively. The PT and APTT 
were elevated in these experiments by the addition of heparin in an effort to make any changes in 
PT or APTT more pronounced. Microscopy showed that no platelets were attached to the 
surface.  
 
5.2 Comparison of Numerical Model with Previous Results 
 
The result of the simulation of flow through the stenosis compared very well with the 
published results [Goodman, 2005]. Figure 12 illustrates the thrombus growth that is similar in 
size, shape and location to that published by Goodman [2005, Fig #13]. The time when the 
thrombus reaches this size is about 30% faster in the current model than calculated in the prior 




Figure 12: Top Left: Schematic of Goodman et al. geometry showing line of symmetry in 
red. Bottom Left: Resulting simulation done as a part of this work, showing attached 
thrombus. The colors identify the grid cells as fluid (blue and light blue), and thrombus 
(red and yellow). Right: Experimental (A and B) and computational (C) results from 
Goodman 2005, pg 788 showing attached thrombus. Note similarity in both size and 
location to Goodman et al. results.  
 
5.3 Annular Gap  
5.3.2 Grid Study 
 
 A grid study of only the fluid motion was conducted. Less than a 1% change in the wall 
shear rate was observed when the grid elements were reduced in size from 10 microns to 2 

























Figure 13: Shear rate at the stationary (inner) wall for three different grid sizes. Less than 
1% change was observed from the 10 micron grid to the 5 micron grid. 
 
 increase in deviation when the grid is reduced from 5 microns to 2 microns. There are two 
potential causes for this increase in deviation. First, it is possible that when a grid is smaller than 
a critical size, the numerical error increases as the grid size decreases. Future work could consist 
of a grid study to determine the critical grid size. A more likely cause of this increase in scatter is 
inability for the 2 micron simulations to converge to the same residual as the 10 and 5 micron 
grids. The 10 and 5 micron grids converged to a residual of 1e-5 for continuity while the 2 




























Figure 14: The shear rate at moving (outer) wall for three different grid sizes. Less than 
1% change was observed from the 10 micron grid to the 5 micron grid.  
 
Another grid study using the entire thrombosis model was then conducted with grid elements of 
10, and 5 microns. Platelet deposition on the wall at 100 sec of flow time was measured for each 
grid. Platelet deposition for the 10 micron grid was over 3 times higher near the center of the 
domain than at the boundaries. The asymmetry observed in the 10 micron grid was eliminated 
when the grid size was reduced to 5 microns as shown in Figure 15. For this reason, a grid size of 
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Figure 15: Normalized platelet deposition on the stationary (inner) wall for grid elements 
of 10 and 5 microns. Platelet Deposition is normalized to the minimum value for each 
simulation for comparison purposes.  
 
5.3.2 Velocity Field 
 
The annular gap geometry generated expected flow properties. The steady-state velocity 
profile was linear, which resulted in a near uniform shear across the entire domain. Because the 
fluid is initially at rest, there is a transitional period in the fluid before it reaches a steady state 
velocity profile (Figure 16). The development time (~0.025 seconds) is short compared to the 
total solution time (>60 seconds) and any shear stresses imparted by this transitional period have 
minimal impact on the final solution.  
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Figure 16: CFD velocity profile development 
 
5.3.3 Platelet Concentrations 
 
 Platelet mass was conserved to within 3% over the 120 sec simulation. This change is 
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Figure 17: Total number of platelets in the simulation at 0.0005, 0.5, 1, 10, 30, and 100 
seconds. The number of platelets deposited on the moving and stationary wall is less than 
3% different than the number of plates lost from the bulk flow at any time.  
  
The mass fraction of resting and activated platelets in the bulk flow decreases over time due 
to platelet deposition. Figure 18 illustrates the higher rate of deposition for activated platelets 
compared to resting platelets.  
Over the three shear rates tested, the mass fraction of thrombin was observed to increase with 
increasing shear (Figure 20). This increase in thrombin is due higher levels of platelet activation 
and deposition.  
Most of the species including thrombin maintained a nearly uniform concentration 
throughout the solution. However, after several seconds of flow time, a concentration gradient 
developed for activated and unactivated platelets across the domain. The center of the domain 
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contained a high concentration of platelets while platelet concentration was low near the walls as 
shown in Figure 19. This is due to the fact that the walls act as a sink for the platelets. As 
platelets deposit on the wall, platelet concectration in the bulk flow near the wall decreases. As 
this process continues in time, a gradient develops with the highest concentration of platelets in 

























Figure 18: The mass fraction of activated and resting platelets decrease over time in the 
CFD simulations. 
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Contours of Mass fraction of ap  (Time=9.9857e+01)
























Figure 19: Activated platelet concentration for the entire computational domain at 100 sec 




































Figure 20: Results from computational simulations demonstrating increasing thrombin 
mass fraction with increasing shear rate. Each point represents an individual CFD 




6 Conclusion and Discussion 
 
6.1 Experimental Insight and Discussion 
 
After exposing whole blood to a specific shear for 120 seconds, PT and APTT were 
measured as described in chapter 3.5.  These tests provide a measure of time until clot formation 
and relative amounts of coagulation factors. A decrease in  PT and APTT would indicate more 
rapid clot formation and higher levels of coagulation factors. Therefore, the results shown in 
Figure 11 indicate that blood exposed to high shear rate contains more coagulation factors than 
blood exposed to a lower shear rate.  
6.2 Numerical Insight and Discussion 
 
Three separate numerical simulations were solved with three different shear rates. As the 
simulation progessed in time, the flow field and the biomaterial surface interacted with the 
species to simulate coagulation as described in chapter 4. In the numerical model, thrombin is 
generated due to platelet activation and platelet deposition as governed by the source terms in 
Table 3. Figure 20 demonstrates that thrombin concentration in the numerical model increases 
with increasing shear rate. Therefore, increasing shear is causing more platelet activation and 
more platelet deposition.  However, increasing the shear rate also increased the rate of 
embolization, so no significant difference in thrombus growth was observed. Another, interesting 
insight is the non-zero thrombin concentration for the 0 shear simulation. This indicates that the 




6.3 Comparison of Numerical and Experimental Results 
 
The trend seen in the experimental results of PT and APTT decreasing with increasing shear 
indicate that higher levels of coagulation factors are present. This is in agreement with the 
numerical models prediction of increasing thrombin and other coagulation factors with 
increasing shear rate. This agreement indicates that the numerical model can qualitatively predict 
the effects of shear on whole blood.  A qualitative evaluation of the numerical model will require 
further research with more suffisticated experiments. This initial evaluation of the numerical 
coagulation model is necessary to guide future research with the ultimate goal of applying this 
model to a mechanical blood pump.  
6.4 Future Improvements to the Experiment 
 
The experimental method and test rig described in this thesis is a baseline for developing an 
experimental apparatus that can conduct controlled experiments studying whole blood in a high 
shear flow field. Ultimately, this apparatus will be similar to a commercial ventricular assist 
device (VAD). Immediate improvements would include: the direct measure of coagulation 
factors, a geometry that induced thrombus formation, and a controller for the DC motor.  The 
validation of the numerical model would benefit from experimentation that directly measured 
values of the individual coagulation factors that are included in the numerical model. A geometry  
that included areas of high and low shear would be a better representation of the blood pathway 
through a poorly designed assist device that is more likely to produce a clot. This geometry 
would provide more information on platelet deposition and thrombus growth that is more readily 
seen in clinical applications. A computer controlled DC motor could provide some interesting 
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experiments such as pulsing the motor on and off. Experiments such as this can demonstrate the 
effect repeated exposure to high (implanted VAD device) and low (venous return) shear on 
whole blood.  
 
6.5 Potential Improvements to the Current Numerical Model 
 
One area of possible improvement to this computational model is the threshold nature of 
platelet activation.  It has been shown that weak agonists (ADP, epinephrine, etc.) and strong 
agonists (thrombin, etc.) act synergistically, and that different concentration combinations of 
each have varying effects [Huang, 1981].  The synergist effect of agonists is current not included 
in the model at all.  
In the current model, agonist induced activation and shear induced activation are two 
completely separate modes of platelet activation. It has been shown that a sub-critical 
concentration of agonists combined with a sub-critical shear rate can produce significant 
amounts of platelet activation. [Anderson, 1978] This synergistic effect of shear and agonists 
could be large source of error for this numerical model. While incorporating the synergistic 
effects would be the best solution, perhaps a more efficient use of resources would be to 
determine the regimes that these synergistic effects would be most influential and evaluate if the 
current numerical model can be applied in these regimes.  
The experiment and the numerical model both showed no signs of clot formation. This is 
likely due to the high shear washing the surface. This agrees with Goodman et al. experimental 
data on embolization (Equation 1). According to Goodman et al., at the shear rate and exposure 
time tested, less than 5% of platelets would remain attached. This type of flow, while uniform 
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and controllable, does not promote thrombogenesis. This numerical model is best suited for 
comparing with experiments that encourage platelet deposition and clot formation.  
In the future, a similar comparison of numerical and physical models should be made for a 
high shear rotating flow that also includes regions of stagnation or recirculation.  
The current numerical model only contains two factors of the coagulation cascade 
(prothrombin and thrombin). These two factors are part of the common pathway (coagulation 
factors that are in the extrinsic and intrinsic pathways).  While these two factors are precursors to 
thrombus formation, the model would benefit from the inclusion of other coagulation factors 
from the individual pathways.  
The current research is an effort to characterize the applicable domain of this numerical 
model. Further investigation into potential applications would greatly benefit the progess of this 
model. Future work could include a parametric analysis of the current research’s results to 
determine the relative importance of individual species to a particular application or flow regime.  
6.6 Potential Clinical Applications of the Numerical Model 
 
As CFD becomes more robust and computational power becomes cheaper, geometries are 
becoming more physiologically realistic. The applicability of this model to physiological 
applications has currently not been tested. However, there are several clinical applications that 
possess a large potential for this model and should be investigated. Some well studied clinical 
cases that thrombosis plays a large role include: vascular stents [Czemak, 2004], aneurysms 
[Nagai, 2008], and the internal carotid artery bifurcation [Kanazawa, 2004]. Each of these cases 
has several publications that provided in vivo computed tomography (CT) measurements of an 




National Heart, Lung, and Blood Institute 1RO1 HL 077085-01A1  
54 
References 
Alevriadou, B. R., J. L. Moake, N. A. Turner, Z. M. Ruggeri, B. J. Folie, M. D. Phillips, A. B. 
Schreiber, M. E. Hrinda, and L. V. McIntire. "Real-Time Analysis of Shear-Dependent 
Thrombus Formation and Its Blockade by Inhibitors of Vonwillebrand-Factor Binding to 
Platelets." Blood 81, no. 5 (1993): 1263-76. 
 
Anderson, G. H., J. D. Hellums, J. L. Moake, and C. P. Alfrey. "Platelet Lysis and Aggregation 
in Shear Fields." Blood Cells 4, no. 3 (1978): 499-507. 
 
Basmadjian, D. "Coagulation on Biomaterials in Flowing Blood: Some Theoretical 
Considerations." In Biomaterials, 1511. [Guildford, Eng.]: IPC Science and Technology 
Press, 1997. 
 
Burgreen, Greg W. "Design Improvement Strategy for Axial Blood Pumps Using Computational 
Fluid Dynamics." In ASAIO journal, M354. Hagerstown, MD: Published for the Society 
by J.B. Lippincott Co., 1996. 
 
Chang, G., D. R. Absolom, A. B. Strong, G. D. Stubley, and W. Zingg. "Physical and 
Hydrodynamic Factors Affecting Erythrocyte Adhesion to Polymer Surfaces." Journal of 
Biomedical Materials Research 22, no. 1 (1988): 13-29. 
 
Czermak, B. V., A. Mallouhi, R. Perkmann, I. E. Steingruber, P. Waldenberger, B. Neuhauser, 
G. Fraedrich, T. Jung, and W. R. Jaschke. "Serial Ct Volume and Thrombus Length 
Measurements after Endovascular Repair of Stanford Type B Aortic Dissection." Journal 
of Endovascular Therapy 11, no. 1 (2004): 1-12. 
 
Day, S. W., McDaniel, J. C., "Piv Measurements of Flow in a Centrifugal Blood Pump: Time-
Varying Flow." In Journal of biomechanical engineering, 254. [New York, N.Y.]: 
American Society of Mechanical Engineers, 2005. 
 
Feuerstein, I. A., S. M. Buchan, T. A. Horbett, and K. D. Hauch. "Platelet Adherence and 
Detachment - a Flow Study with a Series of Hydroxyethyl Methacrylate-Ethyl 
Methacrylate Copolymers Using Video Microscopy." Journal of Biomedical Materials 
Research 25, no. 2 (1991): 185-98. 
 
Fogelson, A. L. "A Mathematical-Model and Numerical-Method for Studying Platelet-Adhesion 
and Aggregation During Blood-Clotting." Journal of Computational Physics 56, no. 1 
(1984): 111-34. 
 
Fogelson, A. L. "Continuum Models of Platelet-Aggregation - Formulation and Mechanical-
Properties." Siam Journal on Applied Mathematics 52, no. 4 (1992): 1089-110. 
 
Fogelson, A. L., H. Y. Yu, and A. Kuharsky. "Computational Modeling of Blood Clotting: 




Folie, B. J., and L. V. McIntire. "Mathematical-Analysis of Mural Thrombogenesis - 
Concentration Profiles of Platelet-Activating Agents and Effects of Viscous Shear-Flow." 
Biophysical Journal 56, no. 6 (1989): 1121-41. 
 
Gartner, M. J., C. R. Wilhelm, K. L. Gage, M. C. Fabrizio, and W. R. Wagner.  "Modeling Flow 
Effects on Thrombotic Deposition in a Membrane Oxygenator." In Artificial organs, 29. 
Malden, MA: Blackwell Science, 2000. 
 
Goodman, Paul D, E. T. Barlow, P. M. Crapo, S. F. Mohammad, and K. A. Solen. 
"Computational Model of Device-Induced Thrombosis and Thromboembolism." In 
Annals of biomedical engineering, 780. Cambridge, Eng.: Blackwell Scientific 
Publications, 2005. 
 
Grabowsk.Ef, E. F. Leonard, and L. I. Friedman. "Effects of Shear Rate on Diffusion and 
Adhesion of Blood-Platelets to a Foreign Surface." Industrial & Engineering Chemistry 
Fundamentals 11, no. 2 (1972): 224-&. 
 
Hellums, J. D. "1993 Whitaker Lecture - Biorheology in Thrombosis Research." Annals of 
Biomedical Engineering 22, no. 5 (1994): 445-55. 
 
Hockin, M. F., K. C. Jones, S. J. Everse, and K. G. Mann. "A Model for the Stoichiometric 
Regulation of Blood Coagulation." Journal of Biological Chemistry 277, no. 21 (2002): 
18322-33. 
 
Hopkins, L. M., J. T. Kelly, A. S. Wexler, A. K. Prasad. "Particle Image Velocimetry 
Measurements in Complex Geometries." In Experiments in fluids, 91. Berlin: Springer 
International, 2000. 
 
Huang, E. M., and T. C. Detwiler. "Characteristics of the Synergistic Actions of Platelet 
Agonists." Blood 57, no. 4 (1981): 685-91. 
 
Hubbell, J. A., and L. V. McIntire. "Platelet Active Concentration Profiles near Growing 
Thrombi - a Mathematical Consideration." Biophysical Journal 50, no. 5 (1986): 937-45. 
 
Hubbell, J. A., and L. V. McIntire. "Visualization and Analysis of Mural Thrombogenesis on 
Collagen, Polyurethane and Nylon." Biomaterials 7, no. 5 (1986): 354-&. 
 
Jacobs, H. A., T. Okano, and S. W. Kim. "Antithrombogenic Surfaces - Characterization and 
Bioactivity of Surface Immobilized Pge1-Heparin Conjugate." In Journal of biomedical 
materials research, 611. Hoboken, NJ: John Wiley Sons, 1989. 
 
Jesty, J., W. Yin, P. Perrotta, and D. Bluestein. "Platelet Activation in a Circulating Flow Loop: 
Combined Effects of Shear Stress and Exposure Time." In Platelets, 143. Edinburgh: 
Churchill Livingstone, 2003. 
 
Jones, M. I., I. R. McColl, D. M. Grant, K. G. Parker, and T. L. Parker. "Protein Adsorption and 
Platelet Attachment and Activation, on Tin, Tic, and Dlc Coatings on Titanium for 
Cardiovascular Applications." In Journal of biomedical materials research, 413. 
56 
Hoboken, NJ: John Wiley Sons, 2000. 
 
Kanazawa, R., S. Kominami, Y. Yoshida, S. Kobayashi, and A. Teramoto. "Middle Cerebral 
Artery Thrombolysis through the Contralateral Internal Carotid Artery - Case Report." 
Neurologia Medico-Chirurgica 44, no. 7 (2004): 372-75. 
 
Keller, K. H. "Effect of Fluid Shear on Mass Transport in Flowing Blood." Federation 
Proceedings 30, no. 5 (1971): 1591-&. 
 
Kleinstreuer, C., M. Nazemi, and J. P. Archie. "Hemodynamics Analysis of a Stenosed Carotid 
Bifurcation and Its Plaque-Mitigating Design." Journal of Biomechanical Engineering-
Transactions of the Asme 113, no. 3 (1991): 330-35. 
 
Lee, D., and J. J. Chiu. "Intimal Thickening under Shear in a Carotid Bifurcation - a Numerical 
Study." Journal of Biomechanics 29, no. 1 (1996): 1-11. 
 
Leonard, E. F., V. T. Turitto, and Grabowsk.Ef. "Role of Convection and Diffusion on Platelet 
Adhesion and Aggregation." Annals of the New York Academy of Sciences 201, no. 
OCT27 (1972): 329-&. 
 
Mann, K. G. "Thrombin Formation." In Chest, 4S: American College of Chest Physicians, 2003. 
 
McKenzie, S. B., Textbook of Hematology. Williams and Wilkins. Baltimore, MD, 1996. 
 
Nagai, M., Y. Koizumi, J. Tsukue, and E. Watanabe. "A Case of Extravasation from a Cerebral 
Aneurysm During 3-Dimensional Computed Tomography Angiography." Surgical 
Neurology 69, no. 4 (2008): 411-13. 
 
Nazemi, M., C. Kleinstreuer, J. P. Archie, and F. Y. Sorrell. "Fluid-Flow and Plaque-Formation 
in an Aortic Bifurcation." Journal of Biomechanical Engineering-Transactions of the 
Asme 111, no. 4 (1989): 316-24. 
 
Panteleev, M. A., N. M. Ananyeva, F. I. Ataullakhanov, and E. L. Saenko. "Mathematical 
Models of Blood Coagulation and Platelet Adhesion: Clinical Applications." Current 
Pharmaceutical Design 13, no. 14 (2007): 1457-67. 
 
Platt, W. R., Color Atlas and Textbook of Hematology. Lippincott, Philadelphia, PA, 1979.  
 
Ramstack, J. M., L. Zuckerman, and L. F. Mockros. "Shear-Induced Activation of Platelets." 
Journal of Biomechanics 12, no. 2 (1979): 113-25. 
 
Schaub, Richard D. "Assessing Acute Platelet Adhesion on Opaque Metallic and Polymeric 
Biomaterials with Fiber Optic Microscopy." In Journal of biomedical materials research, 
460. Hoboken, NJ: John Wiley Sons, 2000. 
 
Song, X., A. L. Thockmorton, H. G. Wood, J. F. Antaki, and D. B. Olsen. "Computational Fluid 
Dynamics Prediction of Blood Damage in a Centrifugal Pump." In Artificial organs, 938. 
Malden, MA: Blackwell Science, 2003. 
57 
 
Sorensen, E. N., G. W. Burgreen, W. R. Wagner, and J. F. Antaki. "Computational Simulation of 
Platelet Deposition and Activation: II. Results for Poiseuille Flow over Collagen." Annals 
of Biomedical Engineering 27, no. 4 (1999): 449-58. 
 
Sorensen, E. N., G. W. Burgreen, W. R. Wagner, and J. F. Antaki. "Computational Simulation of 
Platelet Deposition and Activation: I. Model Development and Properties." In Annals of 
biomedical engineering, 436. Cambridge, Eng.: Blackwell Scientific Publications, 1999. 
 
Stiene-Martin, A. E., Lotseich-Stheininger, C. A., Koepke, J. A., Clinical Hematology: 
principles, procedures, correlations. Lippincott-Ravenm Philedelphia, PA, 1998.  
 
Strong, A. B., G. D. Stubley, G. Chang, and D. R. Absolom. "Theoretical and Experimental-
Analysis of Cellular Adhesion to Polymer Surfaces." Journal of Biomedical Materials 
Research 21, no. 8 (1987): 1039-55. 
 
Tritton, D. J., 2003, Physical Fluid Dynamics, Oxford University Press, New York, NY, Chap. 
16, 17. 
 
Turitto, V. T., and H. R. Baumgartner. "Effect of Temperature on Platelet Interaction with 
Subendothelium Exposed to Flowing Blood." Haemostasis 3, no. 4 (1974): 224-36. 
 
Turitto, V. T., and H. R. Baumgartner. "Platelet Deposition on Subendothelium Exposed to 
Flowing Blood - Mathematical-Analysis of Physical Parameters." Transactions American 
Society for Artificial Internal Organs 21, (1975): 593-601. 
 
Turitto, V. T., R. Muggli, and H. R. Baumgartner. "Physical Factors Influencing Platelet 
Deposition on Subendothelium - Importance of Blood Shear Rate." Annals of the New 
York Academy of Sciences 283, no. FEB10 (1977): 284-92. 
 
Untaroiu, A., H. G. Wood, P. E. Allaire, A. L. Thockmorton, S. Day, S. M. Patel, P. Ellman, C. 
Tribble, and D. B. Olsen. "Computational Design and Experimental Testing of a Novel 
Axial Flow Lvad." In ASAIO journal, 702. Hagerstown, MD: Published for the Society 
by J.B. Lippincott Co., 2005. 
 
Wagner, C. T., M. H. Kroll, T. W. Chow, J. D. Hellums, and A. I. Schafer. "Epinephrine and 
Shear Stress Synergistically Induce Platelet Aggregation Via a Mechanism That Partially 
Bypasses Vwf-Gp Ib Interactions." Biorheology 33, no. 3 (1996): 209-29. 
 
Wagner, W. R., J. A. Hubbell, L. V. McIntire, and K. G. Mann. "Importance of Thrombin 
Synthesis in Mural Thrombosis on Collagen-Coated Glass." Arteriosclerosis 8, no. 5 
(1988): A672-A72. 
 
Wootton, D. M., C. P. Markou, S. R. Hanson, and D. N. Ku. "A Mechanistic Model of Acute 
Platelet Accumulation in Thrombogenic Stenoses." Annals of Biomedical Engineering 
29, no. 4 (2001): 321-29. 
 
Zydney, A. L., and C. K. Colton. "Augmented Solute Transport in the Shear-Flow of a 
58 




Appendix A Implementation into Fluent 
 
 
 The following is a case specific guide to loading and solving the 
Concentric Cylinder case file in Fluent 6.3.2.  
 
1. Read the .cas file. 
2. Check the grid 
3. Scale the grid – I used 1e-3 for both x and y.  
4. Choose the correct solver: Define – Models – Solver 
a. Unsteady 
b. All others are default 
5. Turn species transport on: Define – Model – Species – Transport and 
Reaction 
a. Species Transport 
b. Volumetric 
c. Wall Surface 
d. Mass Deposition Source 
6. Compile and Load the UDF: Define – User Defined – Functions – 
Compiled 
a. Click Add 
i. Select your C-code file from the list and click OK 
b. Library Name is the name of the folder that will be created and 
contain the compiled UDF files. A directory of the same name 
should already exist in the working directory.  
c. Click build 
i. A prompt will appear to make sure the C-code file and the 
mesh or case file are in the same directory. Make sure this 
is true and click OK 





d. Click Load 
i. If it works correcly, the fluent screen should look 





7. Set Function Hooks: Define – User Defined – Function Hooks 
a. Click edit next to Adjust 
i. select “adjust:libudf” and click add. Then click OK. 
b. Click the drop down arrow next to Surface Reactions 
i. Select surface_reactions::libudf 
8. Set User Defined Memory allocations: Define – User Defined – Memory 
a. 17 – this number must be exacly correct or you will get errors 
when you attempt to iterate.  
i. This is the number of memory allocation set in the UDF 
IV 
9. Define the material: Define –Material  all of the commands below are 
in the Materials panel 
a. Material Type – mixture 
i. Change Density to volume-weighted-mixing-law 
ii. Click Change/Create 
b. Material Type – Fluid  
i. Copy liquid water from the Fluent Database 
ii. Change the name to blood 
iii. Delete the Chemical Formula 
iv. Density – 1056 
v. Click Change/Create and Overwrite H20 
c. Now enter each individual species (rp, ap, dp, adp, txa2, pt, th, 
at) with their molecular weights. The Material Type should be 
Fluid for all species 
i. Enter the species name in the Name box e.g. rp 
ii. Enter the molecular weight from Table 5 
iii. Click Change/Create and don’t overwrite 
iv. Repeat 
d. Material Type – Mixture 
i. Mixture Species – Edit 
1. Move the species from the Available Materials box to 
the Selected Species box in the following order : rp, 
ap, ADP, txa2, pt, th, at, blood  (this must be the 
same order they are listed the UDF code) 
2. remove any other species that are in the Selected 
Species box 
3. Move dp to the Selected Solid Species box.  
4. click OK 
ii. Reaction – Edit 
1. Use arrows to change values in this menu 
2. Total Number of Reactions – 4 
3. Reaction Type – Wall Surface  
a. Make sure to click the Wall Surface radio 
button for all four of the reactions. 
4. Enter the following stoichiometry reactions in the 
given order. All Rate Exponent values should be 
zero.  
a. Reaction 1 
i.  Reactants:1 rp  
ii. Products: 1 dp 
b. Reaction 2 
i. Reactants: 1rp  
ii. Products: 1dp 
c. Reaction 3 
V 
i. Reactants: 0 ap  
ii. Products: 0ap + 1 txa2 
d. Reaction 4 
i. Reactants: 1 pt  
ii. Products: 1 th 
e. All Arrhenius Rate values should remain as 
defaults 
5. Click OK 
iii. Viscosity – User Defined 
iv. Mass Diffusivity – User Defined 
v. Click Change/Create and Close the Materials Window 
10. Set Boudary Conditions: Define – Boundary Conditions 
a. Bot wall 
i. Species Tab 
1. Check the Reaction box 
b. Fluid  
i. Reaction box should be checked if it is not already 
ii. Check the Source Terms box 
iii. Source Terms Tab 
1. Click the Edit box next to the species you wish to 
add a source term to.  
2. Select the source term for the appropriate species 
given in the list below 
a. rp – rp_source and rp_init 
b. ap – ap_source and ap_init 
c. adp – adp_source 
d. txa2 – txa2_source 
e. pt – pt_source and pt_init 
f. th – thrombin_source 
g. pt – at_source and at_init  
3. click OK 
c. Outs  
i. Change the Periodic Type to Rotational 
d. Topwall 
i. Click the Moving Wall radio button 
ii. Click the Absolute and Rotational radio buttons 
iii. Enter the desired rotational speed in rad/sec 
1. For high rotational speeds and shear rates, it can 
help the stability of the problem to start at a low 
rotational speed, solve the velocity field, and then 
raise the rotational speed and continue solving. 
Sometimes many small steps like this are necessary 
to avoid a divergent solution.  
VI 
2. For a shear rate of 10,000 s-1 a rotational speed of 
220 rad/sec is used.  
iv. Species Tab 
1. Check the Reaction check box 
e. Close the Boundary Condition Window 
11. Set Solution Controls: Solve – Controls – Solution 
a. Different computers require different Under-relaxation factors 
and Pressure-velocity coupling. I have had mixed results using 
the PISO and SimpleC couplers. Sometimes they work great and 
other times the solution divergese. But when they do work, they 
solve much faster than Simple. It is a good idea to lower the 
Momentum, rp, and ap Under-relaxation factors to about half of 
their default values.  
b. Click OK 
12. Initialize the problem: Solve – Initialize – Initialize 
a. Compute From – all zones 
b. For the given rotational speed of the outer wall or topwall 
determine the average steady state velocity and enter this in Y-
velocity box 
c. Click Init and Close the Initialization Window 
13. Set the Residuals: Solve – Monitors – Residual 
a. Set continuity, x-velocity, y-velocity and rp to 1e-5. Set ap to 
5e-5.  
b. Click OK 
14. Solve the Problem: Solve - Iterate 
a. Click the Adaptive Time Step radio button 
b. Enter the desired number of time steps 
c. I have not had good luck trying to start the simulation with a 
time step larger than 1e-5.  
d. Change the Max Iterations per Time Step to 200 
e. Leave the Adaptive Time Step Parameters as default 
f. Click Iterate 








On a 64-bit machine running Windows x64, the full version of Visual 
Studio is needed to compile a UDF. Visual Studio 2005 Standard Edition 
was used for the current research. On a 32-bit machine, Visual Studion 
Express can be used and is a free download from Microsoft. Fluent must 
be opened in the Visual Studio command prompt (x64 Win64 command 




Appendix C Source Code 
 





/* global variables */ 
 
/* physical constants, misc.*/ 
int wall1_ID = 5; 
int wall2_ID = 6; 
 
int interior_ID = 8; 
real flow_rate = 0;  
real visc =.00325;  
int partition = 2;  
 
/* platelet info */  
real plt_count = 300.;  
real minf = 6.0e10;  
real test;  
 
/* kinetic variables */ 
int thrombus_count = 1; 
real krs = 0.0000025;  
real kas = 0.0035;  
real kt = 0.0035;  
real tact = 1.0;  
real temb = 120.0;  
 
/* global time for initial concentrations */ 
real delt_int = 0.00001; 
 
/* User-Defined Memory Allocations. This stores the data to access it later. */  
int M=0;   /*C_UDMI(c,t,0)=M(x,t), total platelet surface coverage (plt/m^2)*/  
int Sa=1;  /*C_UDMI(c,t,l)=Sa(x,t), unitless, % avalailable surface area ()*/  
int rpadh=2; /*C_ MI(c,t,2)=flux of unact. plts to the surface (plt/ ^2-s)*/  
int apadh=3; /*C_UDMI(c,t,3)=flux of act. platelets to the surface (plt/m^2-s)*/ 
int upemb=4; /*C_UDMI(c,t,4)=flux of act. pits embolizing (plt/m^2-s)*/  
int delthu=5; /*C_UDMI(c,t,5)=delta thrombus, unitless, change in vol% of grid  
 cell changing to unactivated thrombus */  
int delth=6; /*C_UDMI(c,t,6)=delta thrombus, unitless, change in volume% of grid  
 cell changing to thrombus */  
IX 
int thrombus=7; /*C_UDMI(c,t,7)=thrombus growth, unitless, % of grid cell that is 
thrombus () */  
int gridid=8; /*C_UDMI(c,t,8)=grid cell type (bulk fluid, thrombus, etc.,  
 unitless () */  
int tcount=9; /*C_UDMI(c,t,9)=thrombus_count, unitless, identifies the cell as part of a 
numbered thrombus () */  
int area=10; /*C_UDMI(c,t,l0)=wall surface area (m^2) */ 
int pltact=11; /* C_UDMI(c,t,11)=platelet activation, calculated from weighted agonist 
concentrations, kg/m^3 */  
int gama=12; /*C_UDMI(c,t,12)=maximum local shear rate in cells adjacent to surface 
(1/s) */  
int Xact=13; /*C_UDMI(c,t,13)=fraction of thrombus/wall that is act. platelets*/  
int actime=14; /*C_UDMI(c,t,14)=time at which a grid cell becomes active (s)*/  
int Ma = 15; /*C_UDMI(c,t,15)=Ma(x,t), act. platelet surface coverage (plt/m2)*/  
int Matime = 16;/*C_UDMI(c,t,16)= time at which the surface of the cell becomes active*/  
/* end global variables */  
 
 
/* Adjust Function keeps track of thrombus*/ 
/* growth, platelet adhesion, etc.*/ 
 
 





Thread *t, *tc1, *ft, *tc0;  
 
cell_t c, c1, c0;  
face_t f;  
real delt,curr_t,A[ND_ND],total_force[ND_ND], adhesion_area;  
int curr_ts, n, th, new, old,p,neighbor;  
new = 0;  
old = 0;  
curr_ts = RP_Get_Integer("time-step");  




   /*The following if loop ensures that the adjust function is calculated only once per 
time step */ 
 
 
if (last_ts != curr_ts) 
 { 
X 
 last_ts = curr_ts;  
 thread_loop_c(t, d)  
  { 
 
  if (FLUID_THREAD_P(t)) /* applies adjust function only to fluid threads*/  
   {  
 
/* Initialization performed only on the first time step*/  
   if(curr_t==delt)  
    {  
    thrombus_count = 1; /*initialize the thrombus ID number*/ 
    begin_c_loop_int(c,t) /*the int applies the loop to cells that are 
inside the partition*/ 
     { 
      C_UDMI(c,t,Sa)=1.; /*initialize Sa(t)*/ 
      C_UDMI(c,t,area) = 0.0; /* initialize area calculation*/ 
     c_face_loop(c,t,n) 
      {  
      f=C_FACE(c,t,n);  
      ft=C_FACE_THREAD (c,t,n);  
      if(THREAD_ID(ft)==wall1_ID || 
THREAD_ID(ft)==wall2_ID)  
       { 
       F_AREA(A,f,ft);  
       C_UDMI(c,t,area) += NV_MAG(A);  
       C_UDMI(c,t,actime)=0.;  
       } 
      } 
     }  
    end_c_loop_int(c,t)  
    } 
/*end first step initialization*/  
 
/* General cell loop to determine thrombus growth, max shear, grid cell type (i.e. thrombus), 
and to identify individual thrombi numerically */  
 
 
  begin_c_loop(c,t)  
  {  
/*calculate the cumulative thrombus growth */  
 
         C_UDMI(c,t,thrombus)=C_UDMI(c,t,thrombus) + 
(C_UDMI(c,t,delth)+C_UDMI(c,t,delthu)) * delt;  
   if(C_UDMI(c,t,thrombus)>=1. )  
    C_UDMI(c,t,thrombus)=1.;  
 
XI 
/* calculate the shear rate in all cells */  
            if (abs(C_DUDX(c,t)) > abs(C_DUDY(c,t)) && abs(C_DUDX(c,t)) > 
abs(C_DVDX(c,t)) && abs(C_DUDX(c,t)) > abs(C_DVDY(c,t)))  
    C_UDMI(c,t,gama) = abs(C_DUDX(c,t));  
            if (abs(C_DUDY(c,t)) > abs(C_DUDX(c,t)) && abs(C_DUDY(c,t)) > 
abs(C_DVDX(c,t)) && abs(C_DUDY(c,t)) > abs(C_DVDY(c,t)))  
    C_UDMI(c,t,gama) = abs(C_DUDY(c,t));  
            if (abs(C_DVDX(c,t)) > abs(C_DUDY(c,t)) && abs(C_DVDX(c,t)) > 
abs(C_DUDX(c,t)) && abs(C_DVDX(c,t)) > abs(C_DVDY(c,t)))  
    C_UDMI(c,t,gama) = abs(C_DVDX(c,t));  
            if (abs(C_DVDY(c,t)) > abs(C_DUDY(c,t)) && abs(C_DVDY(c,t)) > 
abs(C_DVDX(c,t)) && abs(C_DVDY(c,t)) > abs(C_DUDX(c,t)))  
    C_UDMI(c,t,gama) = abs(C_DVDY(c,t));  
 
 
/* identify cells as  
(0) interior fluid;  
(1) wall fluid;  
(2) wall thrombus;  
(3) interior thrombus;  
(4) interior fluid with thrombus neighbor; and  
(5) wall fluid with thrombus neighbor */ 
 
   C_UDMI(c,t,gridid) = 0;  
   if (C_UDMI(c,t,thrombus)==1.)  
    {  
    C_UDMI(c,t,gridid) = 3;  
    if(C_UDMI(c,t,actime)==0. && C_UDMI(c,t,gama)>0.)  
     C_UDMI(c,t,actime)= 
curr_t+4.0e6*pow(C_UDMI(c,t,gama)*0.035,-2.3);  
    if(curr_t >= C_UDMI(c,t,actime) || C_UDMI(c,t,pltact)>0.)  
     C_UDMI(c,t,Xact)= 1.;  
    }  
   c_face_loop(c,t,n)  
    {  
    ft=C_FACE_THREAD(c,t,n); 
    f=C_FACE(c,t,n);  
    c0 = F_C0(f,ft);  
    tc0 = F_C0_THREAD(f,ft); 
    c1 = F_C1(f,ft);  
    tc1 = F_C1_THREAD(f,ft);  
    if (PRINCIPAL_FACE_P(f,ft))  
     {  
     if(THREAD_ID(ft)==wall1_ID || 
THREAD_ID(ft)==wall2_ID)  
      {  
XII 
      if (C_UDMI(c,t,thrombus) == 1.)  
      C_UDMI(c,t,gridid) = 2;  
      if (C_UDMI(c,t,thrombus) < 1.)  
       {  
       if(C_UDMI(c,t, gridid)!=5 )  
       C_UDMI(c,t,gridid) = 1;  
 
/* calculate the new M(x,t) value: M = M+(jr+ja-Memb)*delt */ 
 
 
      
 C_UDMI(c,t,M)=C_UDMI(c,t,M)+(C_UDMI(c,t,rpadh)+C_UDMI(c,t,apadh)-
C_UDMI(c,t,upemb))*delt;  
       if (C_UDMI(c,t,M) > minf)  
       C_UDMI(c,t,M) = minf;  
/* calculate the new fraction of activated platelets value*/  
       C_UDMI(c,t,Ma) = C_UDMI(c,t,Ma) + 
C_UDMI(c,t,apadh)*delt;  
 
   /*calculate the new Sa(t) value: Sa=1-M/minf*/  
       C_UDMI(c,t,Sa)=1.-C_UDMI(c,t,M)/minf;  
       if (C_UDMI(c,t,Sa)<0.)  
       C_UDMI(c,t,Sa)=0.;  
       if(C_UDMI(c,t,Matime)==0. && 
C_UDMI(c,t,gama)>0.)  
       C_UDMI(c,t,Matime) = 
4.0e6*pow(C_UDMI(c,t,gama)*0.035,-2.3);  
       if(curr_t >= C_UDMI(c,t,Matime) && 
C_UDMI(c,t,Matime)>0.)  
        {  
        C_UDMI(c,t,Ma)=C_UDMI(c,t,M);  
        if(C_UDMI(c,t,actime)==0. && 
C_UDMI(c,t,gama)>0.)  
        C_UDMI(c,t,actime) = 
4.0e6*pow(C_UDMI(c,t,gama)*0.035,-2.3);  
        if(curr_t >= C_UDMI(c,t,actime) 
&& C_UDMI(c,t,actime)>0.)  
        C_UDMI(c,t,Xact)=1.; 
        } 
       } 
      } 
     if (THREAD_ID(ft)==interior_ID) 
      { 
      if (C_UDMI(c0,tc0,thrombus) == 1. && 
C_UDMI(c,t,gridid) == 0 && C_UDMI(c,t,thrombus)< 1.)  
       {  
XIII 
       C_UDMI(c,t,gridid) = 4;  
      
 C_UDMI(c,t,tcount)=C_UDMI(c0,tc0,tcount); 
/*C_UDMI(c,t,tcount) is the thrombus*/ 
       } 
      if (C_UDMI(c1,tc1,thrombus) == 1. && 
C_UDMI(c,t,gridid) == 0 && C_UDMI(c,t,thrombus)< 1.)  
       {  
       C_UDMI(c,t,gridid) = 4;  
      
 C_UDMI(c,t,tcount)=C_UDMI(c1,tc1,tcount);  
       } 
      if (C_UDMI(c0,tc0,thrombus) == 1. && 
C_UDMI(c,t,gridid) == 1 && C_UDMI(c,t,thrombus)< 1.)  
       {  
       C_UDMI(c,t,gridid) = 5;  
      
 C_UDMI(c,t,tcount)=C_UDMI(c0,tc0,tcount);  
       } 
      if (C_UDMI(c1,tc1,thrombus) == 1. && 
C_UDMI(c,t,gridid) == 1 && C_UDMI(c,t,thrombus)< 1.)  
       {  
       C_UDMI(c,t,gridid) = 5; 
      
 C_UDMI(c,t,tcount)=C_UDMI(c1,tc1,tcount);  
       } 
      }  
     }  
    }  /*end of the face loop and if principle_f */  
   } 













/* to avoid duplication, each partition is evaluated serially */  
 for(p=0; p <= partition-1; p++)  
  { 
XIV 
  thrombus_count=PRF_GIHIGH1(thrombus_count); 
  if (p==myid) 
   { 
   begin_c_loop(c,t) 
    {  
    if(C_UDMI(c,t,thrombus)==1.)  
     {  
     neighbor = 0;  
     if(C_UDMI(c,t,tcount)==0)  
      {  
      c_face_loop(c,t,n)  
       {  
       ft=C_FACE_THREAD(c,t,n); 
       f=C_FACE(c,t,n);  
       c0 = F_C0(f,ft);  
       tc0 = F_C0_THREAD(f,ft);  
       c1 = F_C1(f,ft);  
       tc1 = F_C1_THREAD(f,ft);  
       if(THREAD_ID(ft)==interior_ID) 
        {  
        if (C_UDMI(c0,tc0,tcount)==0)  
         {  
         if 
(C_UDMI(c1,tc1,tcount)==0)  
          {  
          neighbor = 0;  
/*Message ("new thrombus \n");*/  
          }  
         else  
          {  
         
 C_UDMI(c,t,tcount)=C_UDMI(c1,tc1,tcount);  
          neighbor = 1;  
                                     /*Message ("neighbor to thrombus %d\n",C_UDMI(c,t,tcount)); */ 
          }  
         }  
        else  
         { 
        
 C_UDMI(c,t,tcount)=C_UDMI(c0,tc0,tcount);  
         neighbor = 1;  
/*Message ("neighbor to thrombus %d\n.", C_UDMI(c,t,tcount)); */  
         } 
        } 
       } /*end of face loop*/ 
      if (neighbor==0)  
XV 
       {  
       C_UDMI(c,t,tcount)=thrombus_count;  
       thrombus_count=thrombus_count + 1;  
/*Message ("new thrombus value assigned");*/  
       }  
      }  
     }  
    }  
   end_c_loop(c,t)  
   }  
             PRF_GSYNC(); /* global sycncronization to make the for loop work across 
partitions */ 
  } /*end for loop*/ 
 
/* calculate the force on thrombi, and determine the probability of embolization */  
 
 for(th=1; th <= thrombus_count-1; th++)  
  {  
  NV_VS(total_force, =, total_force, *, 0.);  
  test = 0.;  
  adhesion_area=0.;  
  begin_c_loop(c,t) /*loops over the cells in the fluid thread*/ 
   { 
   if(C_UDMI(c,t,tcount)==th)  
    {  
    if (C_UDMI(c,t,gridid)>= 2)  
     {  
     c_face_loop(c,t,n) 
      { 
      ft=C_FACE_THREAD(c,t,n);  
      f=C_FACE(c,t,n);  
      c0 = F_C0(f,ft);  
      tc0 = F_C0_THREAD(f,ft);  
      c1 =F_C1(f,ft); 
      tc1 = F_C1_THREAD(f,ft); 
      if (THREAD_ID(ft)==interior_ID) 
       { 
/*if thrombus neighbor, calculate the net force on the thrombus*/  
       if (C_UDMI(c,t,gridid) == 4 || 
C_UDMI(c,t,gridid)==5)  
        {  
        if (C_UDMI(c0,tc0,thrombus) == 1.) 
         {  
         F_AREA(A,f,ft);  
         NV_V_VS(total_force, =, 
total_force, +, A, *, F_P(f,ft));  
XVI 
   /*Message ("pressure at c0 face is %d\n",F_P(f,ft));*/  
         } 
        if (C_UDMI(c1,tc1,thrombus) == 1.)  
         {  
         F_AREA(A,f,ft);  
         NV_V_VS(total_force, =, 
total_force, -, A, *, F_P(f,ft));  
/*Message ("pressure at c1 face is %d\n",F_P(f,ft));*/  
         } 
        } /*end if thrombus neighbor*/  
 
/*check thrombi for adjacent thrombi and merge them*/  
       if (C_UDMI(c,t,gridid) == 2 || 
C_UDMI(c,t,gridid) == 3)  
        {  
        if (C_UDMI(c0,tc0,tcount) < 
C_UDMI(c,t,tcount) && C_UDMI(c0,tc0,tcount) != 0)  
         {  
         old = C_UDMI(c,t,tcount);  
         new = 
C_UDMI(c0,tc0,tcount);  
         C_UDMI(c,t,tcount) = 
C_UDMI(c0,tc0,tcount);  
                            /*Message ("neighbor found c0 %d,%d,%d\n",old, new, 
thrombus_count);*/ 
                            /*begin_c_loop(c,t) 
 
                            { 
                            if (C_UDMI(c,t,tcount) == new) 
                                C_UDMI(c,t,tcount) = old; 
                             } 
       end_c_loop(c,t) new = 0;  
       old = 0;*/  
         } 
        if (C_UDMI(c1 ,tc1,tcount) < 
C_UDMI(c,t,tcount) && C_UDMI(c1,tc1,tcount) != 0)  
         {  
         old = C_UDMI(c,t,tcount);  
         new = 
C_UDMI(c1,tc1,tcount);  
    /*Message ("neighbor found c1 %d,%d,%d\n",old, new, 
thrombus_count);*/  
         C_UDMI(c,t,tcount) = 
C_UDMI(c1,tc1,tcount);  
         /*begin_c_loop(c,t)  
          {  
XVII 
          if 
(C_UDMI(c,t,tcount) == new)  
          C_UDMI(c,t,tcount) 
= old;  
          } 
         end_c_loop(c,t)  
         new=0;  
         old = 0;*/  
         } 
        } /*end if thrombus*/  
       } 
      }  
     /*begin_c_loop(c,t)  
      {  
      if (C_UDMI(c,t,tcount) == new)  
      C_UDMI(c,t,tcount) = old;  
      }  
     end_c_loop(c,t)  
     new = 0;  
     old = 0;  
     if (new != 0)  
     C_UDMI(c,t,tcount)=new;  
     new = 0;*/  
     } 
    } 
   if (C_UDMI(c,t,tcount) == th && C_UDMI(c,t,gridid)==2) 
    { 
    adhesion_area=adhesion_area+C_UDMI(c,t,area);  
    } 
   } 
  end_c_loop(c,t)  
  PRF_GRSUM1(adhesion_area);  
  test = NV_MAG(total_force);  
  PRF_GRSUM1(test); 
 
  test = test*0.1/adhesion_area;  
  if(test>0.0)  
   {  
   Message ("thrombus id = %d\n", th);  
   Message ("total force (dyne/cm^2) = %g\n", test);  
   Message ("adhesion area = %g\n", adhesion_area);  
   Message ("neighbor found %d\n",new);  
   }  
  if (test > 500.)  
   {  
   begin_c_loop(c,t)  
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    {  
    if (C_UDMI(c,t,gridid) == 5 || C_UDMI(c,t,gridid) == 2 || 
C_UDMI(c,t,tcount) == th)  
     {  
     C_UDMI(c,t,gridid) = 1;  
     C_UDMI(c,t,M) = 0.;  
     C_UDMI(c,t,thrombus) = 0.;  
     C_UDMI(c,t,tcount) = 0;  
     }  
    if (C_UDMI(c,t,gridid) == 4 || C_UDMI(c,t,gridid) == 3 || 
C_UDMI(c,t,tcount) == th) 
     {  
     C_UDMI(c,t,gridid) = 0;  
     C_UDMI(c,t,M) = 0.;  
     C_UDMI(c,t,thrombus) = 0.;  
     C_UDMI(c,t,tcount) = 0;  
     }  
    }  
   end_c_loop(c,t)  
   }  
  } /* end for loop*/ 
 if (new !=0) 
  {  
  begin_c_loop(c,t)  
   {  
   if (C_UDMI(c,t,tcount) == new)  
    C_UDMI(c,t,tcount) = old;  
   } 
  end_c_loop(c,t)  
  new = 0;  
  old = 0;  










real mu_lam;  
/* set viscosity to 100 if the cell is thrombus*/  
mu_lam = visc;  
if (C_UDMI(c,t,thrombus)>=1.) 
 mu_lam = 100.;  
XIX 
return mu_lam;  
} 
 




real x[ND_ND], y;  
face_t f;  
begin_f_loop(f,thread)  
 {  
 F_CENTROID(x,f,thread);  
 y=x[1];  
/*v = 2Q/A(1-(r/R)^2)*/  
 /*F_PROFILE(f,thread,position)= flow_rate*0.1179*(1-y*y/9.0e-8);  
 }  









real source,omega,area,thrombus,A[ND_ND];  
int n;  
face_t f;  
cell_t c1, c0;  
Thread *ft, *tc1, *tc0;  
 
/* calculate bulk platelet activation */ 
 
omega=528000.*(2.357 *C_YI(c,t,2)+9.362*C_YI(c,t,3)+6.01*C_YI(c,t,5)); 
if (omega > 1) 




/* calculate source term for each cell */ 
 
if (C_UDMI(c,t,gridid)==0)  
 source = - C_UDMI(c,t,pltact);  /* kg/m"3*/  
if(C_UDMI(c,t,gridid)==1 || C_UDMI(c,t,gridid)==5)  
 {  
/*initialize so grid cells with two wall sides can be correctly counted*/ area=0.;  
XX 
 thrombus = 0.;  
 
 c_face_loop(c,t,n)  
  {  
  ft=C_FACE_THREAD(c,t,n); 
  f=C_FACE(c,t,n); 
  c0 = F_C0(f,ft);  
  tc0 = THREAD_T0(ft);  
  c1 =F_C1(f,ft);  
  tc1 = THREAD_T1(ft);  
  if (PRINCIPAL_FACE_P(f,ft))  
   {  
   if(THREAD_ID(ft)==interior_ID) 
    { 
    if (C_UDMI(c0,tc0,gridid) == 2 || C_UDMI(c0,tc0,gridid) == 3)  
     {  
     F_AREA(A,f,ft);  
     area = NV_MAG(A);  
     thrombus = thrombus + 
C_UDMI(c0,tc0,Xact)*kt*C_YI(c,t,0)* 1056*area/C_VOLUME(c,t); /*kg/m^3*/  
     }  
    if (C_UDMI(c1,tc1,gridid) == 2 || C_UDMI(c1,tc1,gridid) == 3)  
     {  
     F_AREA(A,f,ft);  
     area = NV_MAG(A);  
     thrombus = thrombus + 
C_UDMI(c1,tc1,Xact)*kt*C_YI(c,t,0)* 1056*area/C_VOLUME(c,t); /*kg/m^3 */  
     }  
    } 
    if(THREAD_ID(ft)==wall1_ID || THREAD_ID(ft)==wall2_ID)  
     {  
     F_AREA(A,f,ft);  
     area = NV_MAG(A);  
     thrombus = thrombus + 
C_UDMI(c,t,Ma)/minf*kt*F_YI(f,ft, 1 )* 1056*area/C_VOLUME(c,t);  /* kg/m^3 */  
     } 
    }  
   } /* end face looop*/ 
       source = -C_UDMI(c,t,pltact) - thrombus; /* kg/m^3*/ 
    C_UDMI(c,t,delthu) = thrombus*0.00472/0.8; /*retums % thrombus, assuming 20% 
void volume*/ 
                /* .0047 comes from vol/mass of platelet: 10.2 fL and 2.12 pg*/ 
 } 
 
 if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)  
  source = 0.;  
XXI 
 if (C_UDMI(c,t,gridid)==4)  
  {  
  area = 0.;  
  thrombus = 0.;  
  c_face_loop(c,t,n)  
   {  
   ft=C_FACE_THREAD(c,t,n); 
   f = C_FACE(c,t,n);  
   c0 = F_C0(f,ft);  
   tc0 = THREAD_T0(ft);  
   c1 = F_C1(f,ft);  
   tc1 = THREAD_T1(ft);  
   if (PRINCIPAL_FACE_P(f,ft) && THREAD_ID(ft) == interior_ID)  
    {  
    if (C_UDMI(c0,tc0,gridid) == 2 || C_UDMI(c0,tc0,gridid) == 3) 
     { 
     F_AREA(A,f,ft); 
     area = area + NV_MAG(A); 
     thrombus = thrombus + 
C_UDMI(c0,tc0,Xact)*kt*C_YI(c,t,0)* 1056*area/C_VOLUME(c,t); /* kg/m^3*/ 
     } 
    if (C_UDMI(c1,tc1,gridid) == 2 || C_UDMI(c1,tc1,gridid) == 3) 
     { 
     F_AREA(A,f,ft);  
     area = area + NV_MAG(A);  
     thrombus = thrombus + 
C_UDMI(c1,tc1,Xact)*kt*C_YI(c,t,0)*1056*area/C_VOLUME(c,t); /* kg/m^3 */ 
     } 
    }  
   } 
 
   source = -C_UDMI(c,t,pltact) - thrombus;  /* kg/m^3 */ 
   C_UDMI(c,t,delthu) = thrombus *0.00472/0.8; /*returns % thrombus, 
assuming 
         20% void volume, see above*/ 
         } 
 dS [eqn] = 0.0;  




/* Source Term for Activated Platelets */ 
DEFINE_SOURCE(ap_source,c,t,dS,eqn)  
{  
real source,thrombus,area,A[ND_ND];  
face_t f;  
XXII 
cell_t c1, c0;  
int n;  
Thread *ft, *tc1, *tc0;  
 
/* calculate source term for each cell  */  
 
if (C_UDMI(c,t,gridid)==0)  
 source = C_UDMI(c,t,pltact);  
if(C_UDMI(c,t,gridid)==1 || C_UDMI(c,t,gridid)==5)  
 { 
 
 /*initialize so grid cells with two wall sides can be correctly counted*/ 
 area = 0.; 
 thrombus = 0.; 
 
 c_face_loop(c,t,n) 
  { 
  ft=C_FACE_THREAD(c,t,n); 
  f=C_FACE(c,t,n); 
  c0 = F_C0(f,ft); 
  tc0 = THREAD_T0(ft); 
  c1 = F_C1(f,ft); 
  tc1 = THREAD_T1(ft); 
  if (PRINCIPAL_FACE_P(f,ft)) 
   { 
   if(THREAD_ID(ft)==interior_ID) 
    { 
    if (C_UDMI(c0,tc0,gridid) == 2 || C_UDMI(c0,tc0,gridid) == 3)  
     {  
     F_AREA(A,f,ft);  






     thrombus = thrombus + 
C_UDMI(c0,tc0,Xact)*kt*C_YI(c,t,1)*1056*area/C_VOLUME(c,t); 
      /*kg/mA3 */ 
     }  
    if (C_UDMI(c1,tc1,gridid) == 2 || C_UDMI(c1,tc1,gridid) == 3)  
     {  
     F_AREA(A,f,ft);  
     area = NV_MAG(A);  
     thrombus = thrombus + 
C_UDMI(c1,tc1,Xact)*kt*C_YI(c,t, 1 )* 1056*area/C_VOLUME(c,t); /*kg/mA3 */  
XXIII 
     }  
    }  
            if(THREAD_ID(ft)==wall1_ID || THREAD_ID(ft)==wall2_ID) 
               { 
               F_AREA(A,f,ft); 
               area = NV_MAG(A); 
               thrombus = thrombus 
+C_UDMI(c,t,Ma)/minf*kt*F_YI(f,ft,1)*1056*area/C_VOLUME(c,t); /* kg/m^3*/ 
               } 
   } 
          } /* end face looop*/ 
      source = C_UDMI(c,t,pltact) - thrombus; /* kg/m^3*/ 
   C_UDMI(c,t,delth) = thrombus*0.00472/0.8; /*returns % thrombus, assuming 
20% void volume*/ 
               /* .0047 comes from vol/mass of platelet: 10.2 fL and 2.12 pg*/ 
 } 
 
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)  
 {  
 C_UDMI(c,t,delth) = 0.;  
 source = 0.;  




 area=0.;  
 thrombus = 0.;  
 c_face_loop(c,t,n)  
  {  
  ft=C_FACE_THREAD(c,t,n);  
  f = C_FACE(c,t,n);  
  c0 = F_C0(f,ft);  
  tc0 = THREAD_T0(ft); 
  c1 =F_C1(f,ft);  
  tc1 = THREAD_T1(ft); 
  if (PRINCIPAL_FACE_P(f,ft) && THREAD_ID(ft) == interior_ID) 
   {  
             if (C_UDMI(c0,tc0,gridid) == 2 || C_UDMI(c0,tc0,gridid) == 3) 
    { 
    F_AREA(A,f,ft); 
    area = area + NV_MAG(A); 
    thrombus = thrombus + 
C_UDMI(c0,tc0,Xact)*kt*C_YI(c,t,1)*1056*area/C_VOLUME(c,t); /* kg/m^3*/ 
    } 
   if (C_UDMI(c1,tc1,gridid) == 2 || C_UDMI(c1,tc1,gridid) == 3)  
    {  
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    F_AREA(A,f,ft);  
    area = area + NV_MAG(A);  
    thrombus = thrombus + C_UDMI(c1,tc1,Xact)*kt*C_YI(c,t,1)* 
1056*area/C_VOLUME(c,t); /*kg/m^3 */ 
   }  
  } 
 } 
source = C_UDMI(c,t,pltact) - thrombus;  
C_UDMI(c,t,delth) = thrombus*0.00472/0.8;  
} 
dS[eqn] = 0.0;  




/* Source Term for Adenosine DiPhosphate (ADP) */ 
DEFINE_SOURCE(adp_source,c,t,dS,eqn)  
{  
real source;  
source = .0046*C_UDMI(c,t,pltact);  
dS [eqn] = 0.0;  








real source;  
if (C_UDMI(c,t,gridid)==0 || C_UDMI(c,t,gridid)==4 || C_UDMI(c,t,gridid)==1 || 
C_UDMI(c,t,gridid)==5)  
   source = 0.164*C_YI(c,t,1)-17.002*C_YI(c,t,3);  
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)  
 source = 0.15;  
dS[eqn] = 0.0;  









real source;  
XXV 
if (C_UDMI(c,t,gridid)==0 || C_UDMI(c,t,gridid)==1 || C_UDMI(c,t,gridid)==4)  
 source = -4.792e9*C_YI(c,t,4)*(3.69e-6*C_YI(c,t,1)+6.5e-7*C_YI(c,t,0));  
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)  
   source = -1.765e4*C_YI(c,t,4)*C_UDMI(c,t,Xact);  
dS [eqn] = 0.0;  









real source,generation,loss;  
if (C_UDMI(c,t,gridid)==0 || C_UDMI(c,t,gridid)==4 || C_UDMI(c,t,gridid)==1)  
 {  
 generation = 4.792e9*C_YI(c,t,4)*(3.69e-6*C_YI(c,t,1) + 6.5e-7 * C_YI(c,t,0)) *0.508;  
 loss = 0.047*C_YI(c,t,6)/(3.5e-9+2.885e-3*C_YI(c,t,5) + 5.96e-4*C_YI(c,t,6) + 
491.423*C_YI(c,t,6)*C_YI(c,t,5))*C_YI(c,t,5)* 1056.;  
 source = generation - loss;  
 } 
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)  
 {  
 generation = 8.973e3 *C_YI(c,t,4)*C_UDMI(c,t,Xact);  
 loss = 0.047*C_YI(c,t,6)/(3.5e-9+2.885e-3*C_YI(c,t,5) + 5.96e-4*C_YI(c,t,6) + 491.423 
*C_YI(c,t,6)*C_YI(c,t,5))*C_YI(c,t,5) * 1056.;  
 
 
 source = generation - loss;  
 }  
dS[eqn] = 0.0;  




/* Source Term for antithrombin HI (at) */ 
DEFINE_SOURCE(at_source,c,t,dS,eqn)  
{  
real source;  
source = -84.077*C_YI(c,t,6)/(3.5e-9+2.885e-3*C_YI(c,t,5)+5.96e-4*C_YI(c,t,6)+491.423 
*C_YI(c,t,6)*C_YI(c,t,5)) *C_YI(c,t,5);  
dS [eqn] = 0.0;  





/* Diffusivity Definition */ 
 
DEFINE_DIFFUSIVITY(Diffusivity, c, t, i)  
{  
real source;  
if (i==0)   
{ 










 source = 2.57e-10;  
  
} 
if (i==3)  
{ 
   source = 2.14e-10;  
    
} 
if (i==4)  
{ 
   source = 6.0e-14*C_UDMI(c,t,gama)+3.32e-11;  
    
} 
if (i==5)  
{ 
   source = 6.0e-14*C_UDMI(c,t,gama)+4.16e-11;  
    
} 
if (i==6)  
{ 
   source = 6.0e-14*C_UDMI(c,t,gama)+3.49e-11;  


















 real source; 
 real curr_int = RP_Get_Real("flow-time"); 
 source = 0; 
 if (curr_int==delt_int) 
 { 
   
  source = 0.0006; 
  dS [eqn]=0.0; 
     
 } 





 real source; 
 real curr_int = RP_Get_Real("flow-time"); 
 source = 0; 
 if (curr_int==delt_int) 
 { 
   
  source = 0.000006; 
  dS [eqn]=0.0; 
   
 } 





 real source; 
 real curr_int = RP_Get_Real("flow-time"); 
 source = 0; 
 if (curr_int==delt_int) 
 { 
   
XXVIII 
  source = 0.000075; 
  dS [eqn]=0.0; 
   
 } 





 real source; 
 real curr_int = RP_Get_Real("flow-time"); 
 source = 0; 
 if (curr_int==delt_int) 
 { 
   
  source = 0.000167; 
  dS [eqn]=0.0; 
   
 } 
 return source; 
} 
 
/* Surface Reaction Rates */ 
DEFINE_SR_RATE(Surface_Reactions, f, t, r, mw, yi, rr)  
{  
Thread *t0=t->t0;  
cell_t c0=F_C0(f,t);  
 
/*Reaction 1: Unactivated platelet adhesion  
 rp --> dp  
rate = Sa*kps*Xrp*rho/mwplt  
to get plt/m^2: kps*Xrp*rho/massplt (hence 4.774e17)*/  
 
if (STREQ(r->name, "reaction-1"))  
 {  
 C_UDMI(c0,t0,rpadh) = C_UDMI(c0,t0,Sa)*krs*yi[0]*4.774e17;  /* plt/m^2-s*/  
 
 
/*Memb = M*(1-exp(-.000309*gama))/temb, units in platelet/m^2  
in the exponent, 0.0095*0.00325 (visc)/0.1(converson to dynes/cm2) */ 
      C_UDMI(c0,t0,upemb)= C_UDMI(c0,t0,M)*(1.-C_UDMI(c0,t0,Xact))*(1.- 
exp(.000309*C_UDMI(c0,t0,gama)))/temb; /* returns plt/m^2-s */  
 
*rr =C_UDMI(c0,t0,Sa)*krs*yi[0]* 1056./mw[0] - C_UDMI(c0,t0,upemb)/6.023e26; /* 
returns rate in kmoles/m^2-s*/ 




/*Reaction 2: Activated platelet adhesion  
ap --> dp rate = Sa*kas*Xap*rho/mwplt */ 
 
if (STREQ(r->name, "reaction-2"))  
 {  
 *rr = C_UDMI(c0,t0,Sa)*kas*yi[1]*1056./mw[1];  /* returns rate in kmoles/m^2-s */ 
 






/*Reaction 3: Release of TxA2 from deposited platelets  dp --> dp + txa2 rate = M*St = 
M(plt/m^2)*(9.5e-21mo1Txa2/plt-s) leave the stoichiometry at 0 for dp, 1 for txa2 */ 
if (STREQ(r->name, "reaction-3"))  
 {  
 *rr = C_UDMI(c0,t0,M)*C_UDMI(c0,t0,Xact)*9.5e-24; /* returns rate in 
kmoles/m^2-s */ 
 }  
 
 
/*Reaction 4: Release of Thrombin from deposited platelets  
 dp + pT --> dp + th  
rate = M*fi*pT = M(plt/m^2)*3.55e-14(kg-blood/plt-s)*Xi[pT]/mwpT stoichiometry for the 
reaction: 1 for pT and th; 0 for dp */ 
 
if (STREQ(r->name, "reaction-4"))  
 {  
 *rr = C_UDMI(c0,t0,M)*C_UDMI(c0,t0,Xact)*3.55e-14*yi[4]/mw[4]; 
/*returns rate in kmoles/m^2-s */ 











To describe the procedure for collection and storage of whole blood. This 
procedure is designed to maintain the physiological properties of blood. The 
blood can then be used in experiments of hemolysis, coagulation, or other 
properties of blood. This procedure is meant to be scaled depending on quantity 






1. Large container (1000ml beaker – 6qt cooking pot) 
2. Ice chest  
3. Ice 
4. Storage container (PETG bottles – PVC blood bag) 
5. __ ft^2 of PVC sheet 
6. Heparin (or other anticoagulant) 
 





Collection of Blood from Slaughter House: 
 
1. Determine amount of blood required.  
2. Determine the large collection container. The container should have a volume 3 
times the amount of blood required, and should also be round. Because the 
blood will never come in contact with this container, material is not a 
consideration. 
3. Cut two pieces of PVC film in the same shape. The shape should be twice as tall 
as the collection container and be wider than the diameter of the container.  
4. Place the PVC shapes on top of each other. Using the heat sealer, create a seal 
about ½” thick on three sides of the PVC. This makes a pouch with one open 
end. This open end is where the blood will come into the pouch.  
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5. Place the PVC pouch inside the large collection container and fold the top of the 
pouch over the side of the collection container. Secure with clips or rubber bands 
of necessary.  
6. Measure the amount of blood required and mark it on the PVC pouch.  
7. Measure the amount of heparin needed and place in the PVC pouch. The 
recommended amount of heparin is 1.5U/ml. This can be changed based on 
individual needs. The activity of a particular heparin should be given on the bottle 
in U/mg. Other anticoagulants can be used in a similar fashion but with different 
quantities.  
8. When using a commercial butcher, have the large collection container with the 
PVC pouch inside and the pre-measured anticoagulant inside the PVC pouch all 
prepared. Hand this to the butcher and they will hand it back to you filled with 
blood.  
9. If a large quantity of blood is being collected (>1L) the blood should be gently 
mixed to ensure the anticoagulant is evenly distributed.  
10. Remove the PVC pouch from the large container. Pour the blood into storage 
container such as PETG bottles or PVC blood bag. Try to avoid foaming the 
blood while pouring. While the PVC pouch can be used to store the blood, it is 
recommended that a different bag be used for storage because of sanitation 
issues.  
11. Place the storage container that is now containing blood on ice for transport.  
12. Label storage container as “Bovine Whole Blood” Also label with the date of 
collection and date to be discarded. The date to be discarded can be up to 60 
days after date of collection. After 60 days, the blood has lost all physiological 
properties.  
13. The blood can now either be used or stored between 2-4 C for a few days. 
Precise time when blood is no longer good is dependent of the experiment being 
preformed on the blood.  
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Appendix E Standard Operating Procedure (SOP) for 
Concentric Cylinders Test Stand 
 
 
This devices is intended to expose a fluid to a controlled shear rate. This is 
done by controlling both the gap between the cylinders and the rate at which 
the outer cylinder rotates. The speed at which the outer cylinder rotates is 
controlled by a DC motor and power supply. Please follow the startup 
procedure below whenever using this device.  
 
  Equipment and Instrumentation  
1) Concentric Cylinder test stand including DC motor  
2) power supply  
3) frequency counter       
 
Procedure 
1) Center the inner cylinder in the outer cylinder  
a) Make sure the pillow blocks of the outer cylinder are tight.  
b) Loosen all the fasteners for the inner cylinder. This includes: the collar 
around the 1.5 stainless steal, and both of the fasterners on the 90 
degree, 0.5 in post holder.  
c) Place the brass sleave in the outer cylinder, then place the inner 
cylinder in the brass sleave. The brass sleave acts as a physical 
centering device for the cylinders.  
d) Tighten the fasteners of the inner cylinder being careful to maintain 
the best possible alignment.  
e) Once all three fasteners are tightened, loosen the fastner holding the 
post the is directly connected to the inner cylinder. Pull the post 
directly up, removing the inner cylinder from the outer cylinder and 
the brass sleave. The post should raise with minimal resistance. If you 
feel resistance, that means the cylinders are misaligned and you 
should begin from step (a) again.  
f) Remove the brass sleave.  
g) Replace the inner cylinder into the outer cylinder. The two cylinders 
should be concentric now. 
2) Place the fluid in the test section.  
3) Expose the fluid to shear stress.  
a) Turn on the power supply. It is recommened that the power supply by 
turned to 0 V when you turn it on.  
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b) Turn up the voltage until the desired RPM is reached.  
i) The Counter reports revolutions/sec, so unit convertions may be 
neccesary.  
c) If the cylinders are misaligned, fluid will spray or foam in the test 
section if high shears are induced. It is recommened that you cover 
the device while in operation.  
4) The fluid and cylinders can now be examined depending on the current 
experimental needs.  
5) The cylinders should be thoroghly washed before the next experiment.  
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Part # Part name Drawing name Vendor
7173628 .75x1.625 in deep groove bearing bearings MSC
p6 6" mounting post thor_p6 thor labs
p14 14" mounting post thor_p14 thor labs
pb1 mounting post base thor_pb1 thor labs
c1525 post clamp and 4.5x4.5 in mounting surface thor_c1525 thor labs
c1501 mounting post clamp thor_c1501 thor labs
ra90 right angle post clamp thor_ra90 thor labs
c1500 compact p-series post clamp thor_c1500 thor labs
c1498 slip on post clamp thor_c1498 thor labs
tr2 1/2" post thor_tr2 thor labs
1LWK8 DC Motor,12v,1/35 HP,2350 RPM,3.8 A,TENV - Gainger
Rig1 Bearing block bearingblock in-house
Rig2 Base Plate base plate in-house
Rig3 Inner cylinder inner cylinder in-house
Rig4 Outer Cylinder outer cylinder in-house  
Table E.1: List of parts in the concentric cylinder test stand. Part# references the vendor 
part # and corresponds to the annotations in the complete assembly drawing. Drawing 
































Appendix G Standard Operating Procedure for PT and 
APTT tests from Stiene-Martin, Clinical Hematology, 
pg. 638-639 
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